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Infectious diseases, with increasing prevalence of antibiotic resistant bacteria, coupled
with the declining rate in discovery of antimicrobial agents, impose one of the most significant
threats to human health. Here we identify 2-C-methyl-D-erythritol 4-phosphate
cytidylyltransferase (CMS) as a valid target for antibiotic development which is an enzyme in
pathogenic organisms that leads to the biosynthesis of isoprene precursor molecules. Isoprene
molecules are one of nature’s most common building blocks that are vital to many biological
metabolic processes and are synthesized via the mevalonic acid dependent (MVA), or
methylerythritol phosphate (MEP) pathway. Vertebrates utilize the MVA pathway, while many
pathogenic bacteria use the MEP pathway for isoprenoid biosynthesis. With separate pathways
expressed between vertebrates and bacteria, the MEP pathway is an attractive target for the
development of effective novel antimicrobial therapeutics. This report kinetically characterizes
two putative isoforms of CMS from Listeria monocytogenes. This study validates a previously
developed high performance liquid chromatography (HPLC) method for the kinetic
characterization of cytidylyltransferase enzymes. Structural homology and sequence analysis of
both putative isoforms of CMS provide new evidence suggesting the lmo0235 gene encodes a

CMS and the lmo1086 gene from Listeria monocytogenes encodes a putative ribitol 5-phosphate
cytidylyltransferase.
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CHAPTER I: INTRODUCTION
2-C-methyl-D-erythritol-4-phosphate Cytidylyltransferase
2-C-methyl-D-erythritol-4-phosphate cytidylyltransferase (CMS EC # 2.7.7.60) is a
member of the cytidylyltransferase family of enzymes, and is essential to many prokaryotic
organisms. CMS is an enzyme that catalyzes the third reaction in the methylerythritol phosphate
(MEP) pathway, a biosynthetic pathway for production of isoprenes. Other names the enzyme is
referred to in literature are IspD (isoprenoid synthesis domain containing), MEP
cytidylyltransferase, CDP-ME synthetase, or YgbP (open reading frame/gene). The MEP
pathway forms the products isopentenyl diphosphate (IPP) and dimethylallyl diphosphate
(DMAPP), which are the phosphate charged precursor molecules of isoprenes, shown in Figure
1. The pathway is also commonly known as the 1-deoxy-D-xylulose 5-phosphate (DOXP/DXP)
pathway. The alternative pathway for isoprenoid synthesis is the mevalonic acid (MVA)
dependent pathway, which is present in vertebrates (Figure 2). The MVA pathway does not
contain the enzyme CMS, thus making it a great target for antimicrobial therapeutic
development.
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Figure 1. Methylerythritol Phosphate Pathway (MEP). Pathway for the biosynthesis of
isoprenoid precursor molecules isopentenyl diphosphate (IPP) and dimethylallyl diphosphate
(DMAPP). Each “P” symbolizes a phosphate group. “CDP” represents Cytidine diphosphate.
Enzyme names: DXS is DOXP synthase, DXR is DOXP reductase, CMS is 2-C-methyl-Derythritol-4-phosphate cytidylyltransferase, CDP-ME kinase is 4-diphosphocytidyl-2-C-methylD-erythritol kinase, MCS is 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase, HDS is 4hydroxy-3-methylbut-2-en-1-yl diphosphate synthase, and HDR is 4-Hydroxy-3-methylbut-2enyl diphosphate reductase. Pathway was made using ChemDraw.

Figure 2. Mevalonic Acid (MVA) Dependent Pathway For Isoprenoid Synthesis In Vertebrates.
Each “P” symbolizes a phosphate group. HMG stands for 3-hydroxy-3-methyl-glutaryl. CoA is
coenzyme A. MVA is mevalonate-3-phosphate-5-kinase. PMVA is phosphomevalonate kinase.
DPMVA ismevalonate-5-pyrophosphate decarboxylase. Pathway constructed using ChemDraw.
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Isoprenoids
Isoprenes, the single unit of terpenes, are one of the most common structural motifs in
biological systems and one of nature’s most common building blocks. Simply, these isoprenoid
molecules are necessary for an organism’s survival and have over 35,000 primary and secondary
metabolites (Chang & Keasling, 2006). Isoprene units can form carbon skeletons ranging from a
few linkages to thousands. Isoprenoids are used in many other biosynthetic pathways and build
vital metabolites for functionality. Some important metabolites include sterols, vitamins, heme,
and ubiquinone (Coenzyme Q) (Ad Heuston, Begley, Gahan, Hill, & Ie, 2012). Sterols are the
third class of lipids that are required for a plethora of cellular processes. Sterols are components
of plasma membranes found abundantly in eukaryotic cells but less in prokaryotic cells. They
play a role in sustaining a liquid ordered state of the membrane that preserves cell membrane
fluidity and functionality by creating lipid “rafts” (Simons & Ehehalt, 2002). Ubiquinone is
found in mitochondrial membranes and plasma membranes of prokaryotes which serves as an
electron carrier in the electron transport chain for the eventual synthesis of ATP.
Isoprene is the most abundant hydrocarbon measurable in the breath of humans, which
emphasizes its significance in biological systems (Gelmont, Stein, & Mead, 1981). The isoprene
emission accounts for around one-third of all hydrocarbons released into the atmosphere by all
organisms (King et al., 2010). Molecules that are biosynthetically synthesized from isoprene
subunits play crucial roles in an organism, such as cell signaling, cell maintenance, enzyme
cofactors, and cell wall synthesis. An organism without some of these functions will undergo cell
death since it will not be able to maintain homeostasis. With the absence of isoprene derivatives,
major metabolic pathways will be halted, thus making CMS a great potential target for antibiotic
therapeutics.
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Isoprene subunits are used in industry today to produce synthetic forms of rubber found
in many daily products. Isoprene-derived compounds are found in common household items
such as cosmetics, food, baby bottles, tires, and essential oils. These compounds are responsible
for some of the pleasant aromas in some cosmetic products. Studies are starting to research
terpenoids for their anti-cancer and anti-inflammatory properties (Sharma, Thulasingam, &
Nagarajan, 2017). Terpenes are being evaluated in cannabis as they can become useful in the
pharmaceutical industry.
Several pathogenic organisms such as Mycobacterium tuberculosis, which causes
tuberculosis (TB), Plasmodium falciparum, the parasite that causes malaria, and Listeria
monocytogenes, which leads to listeriosis, use the MEP pathway for isoprene biosynthesis.
Listeriosis, commonly known as food poisoning, affects about 1,600 individuals per year and is
most likely to sicken pregnant women and newborns (Center for Disease Control and Prevention
[CDC], 2017). Tuberculosis is one of the top 10 causes of death worldwide. In 2015, 10.4
million people fell ill with TB and 1.8 million died from the disease (World Health Organization
[WHO], 2017). In 2015, there were 214 million cases of malaria worldwide resulting in an
estimated 438,000 deaths (WHO, 2017). These are just a few organisms of interest although
many more can be included as potential targets. Since the biosynthesis of isoprenoids occur in
separate pathways it opens up possibilities for next generation antibacterial therapeutics that can
target CMS without having adverse effects on vertebrates (humans) which utilize the
mevalonate-dependent pathway. Growing antibiotic resistance is becoming an issue of concern
which makes the development of novel antibiotics a pressing issue for human society. An
enzyme target like CMS may not lead to just curing diseases but improving the quality of life of
millions of individuals around the world..
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Listeria Monocytogenes
Listeria monocytogenes is the pathogenic gram-positive bacterium that causes listeriosis.
Gram-positive bacteria simply means the bacterial cell wall contains peptiodoglycan. Listeria is
very tough to evade as it has the capability to grow in absence or presence of oxygen (facultative
anoerobe), and to replicate and grow at 0 °C (Ramaswamy et al., 2007). This is of great concern
as typical refrigeration temperatures around 0 °C to prevent bacterial growth, although this
temperature will not affect the ability of Listeria monocytogenes to grow. The bacteria are motile
with a flagella at temperatures less than 30 °C but not usually under host biological conditions of
about 37 °C (Gründling, Burrack, Bouwer, & Higgins, 2004). With the bacteria’s ability to grow
in low temperatures, it is recognized as a hazard to the food industry. Listeria monocytogenes has
been associated with such foods as raw milk, pasteurized milk, cheeses, raw vegetables, raw and
cooked poultry, and raw meats. It is known to cause food-borne illness, enter and escape cells
frequently, and evade the body’s immune response systems. It seems that Listeria originally
evolved to invade membranes of the intestines, as an intracellular infection, and developed a
chemical mechanism to do so. This involves the bacterial protein internalin that acts as a ligand
that attaches to a protein, cadherin on the intestinal cell membrane and allows the bacteria to
invade the cells through a zipper mechanism (Robbins et al., 1999). A zipper mechanism is a
form of phagocytosis when a cell engulfs surrounding material and allows it to flow freely in a
small vacoule inside a cell. Once inside the cell, Listeria is able to escape the vacuole and enter
the cytosol through the use of listeriolysin O (LLO) (Portnoy, Auerbuch, & Glomski, 2002).
Motility in the intracellular space is due to actin assembly-inducing protein (ActA) which allows
the bacteria to recruit the host cell's actin polymerization machinery to polymerize the
cytoskeleton to give the bacterial cell motility (Portnoy et al., 2002). The same ActA mechanism
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also allows the bacteria to travel from cell to cell. Although not one of the most common
diseases, listeriosis is of concern for pregnant patients, neonates, elderly, and
immunocompromised individuals.
While CMS is a promising target for novel drug therapeutics, it is far from being well
understood and is very understudied. Much like bacterial cell wall biosynthesis, which has been
so successfully targeted by antibacterial agents, the MEP pathway is essential for microbial
growth, and none of the enzymes of this pathway are present in mammalian cells. Some of the
recent discoveries for antibiotic development generally proceed through five phases, including
target identification, target validation, lead molecule identification, lead molecule optimization,
and preclinical and clinical trials. This thesis project will focus on target identification, which
will be choosing the CMS enzyme in the MEP pathway, and target validation studies by
obtaining kinetic information. In order to design effective CMS therapeutics, foundational
kinetic research must be performed.
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Structure Overview of E. coli CMS
The E. coli CMS isoform is a good model for Listeria monocytogenes CMS 1086 and
CMS 0235. Although using the E. coli as a model for bi-functional CMS enzymes that contain 2
functions due to gene fusion events is less comparable, although this is not the case for CMS
1086 and CMS 0235. Using CMS from E.coli as a model, the enzyme is a homodimeric protein
with an important structural interlocking arm (Richard et al., 2004). This interlocking arm is
essential to protein stability and function. The homodimer of the E. coli variant contains two
active sites with one on each identical subunit and the interlocking arm lodges itself into the
active site of the neighboring subunit to perform catalysis. The interlocking arm domain is a
small segment of residues 137-159, while the larger domain is the globular domain with residues
1-136 and 160-236. The protein contains a modified Rossmann motif that is commonly found in
proteins that bind nucleotides. A Rossmann motif is an alternating pattern of parallel β-sheets
connected by α-helices in a βαβ folding pattern (Hanukoglu, 2015). The E. coli CMS appears to
contain this motif with the exception of one β-sheet oriented in an antiparallel direction (Figure
3). The interlocking arm region contains a series of β-sheets from one subunit interacting in an
antiparallel orientation with the β-sheets of the neighboring subunit.
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Figure 3. Structure of E. coli CMS Monomeric Unit Displaying the Rossmann Motif (PDB
1INJ). Rossmann fold β-sheets are numbered, 1-7. Structure image made using RasMol, αhelices are yellow, β-sheets are green, and the interlocking arm region is red.
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Ribitol 5-phosphate Cytidylyltransferase (RCT)
Ribitol 5-phosphate cytidylyltransferase (TarI or RCT EC # 2.7.7.40) catalyzes a
similar reaction to CMS and is part of the pathway necessary for biosynthesis of wall techoic
acids (WTAs) in gram positive bacteria. The reaction catalyzed is the conversion of CTP and
ribitol 5-phosphate to CDP-ribitol, a vital intermediate in the biosynthesis of WTA (Baur,
Marles-Wright, Buckenmaier, Lewis, & Vollmer, 2009). The WTA synthesis pathway is separate
from the MEP pathway, but upon closer analysis RCT and CMS enzymes display structural
similarities. Inhibition of RCT is a potential target for antibiotic development through inhibition
of the WTA pathway. The structure of RCT is similar to CMS, which is a homodimer protein
containing the interlocking arm and Rossmann like motif, however only three structures have
been solved for a ribitol 5-phosphate cytidylyltransferase.
Cell Wall Techoic Acid
Teichoic acids are the major cell wall components of the pathogenic bacterial
Staphylococcus aureus, Staphylococcus saprophyticus, and Listeria monocytogenes. Teichoic
acids were discovered in 1958 by Armstrong and co-authors (Armstrong, Baddiley, Buchanan,
Carss, & Greenberg, 1958). Techoic acids are made up of anionic polymers of glycerol
phosphate or ribitol phosphate, with phosphodiester linkages (Neuhaus & Baddiley, 2003). Wall
teichoic acid (WTA), which is covalently linked via a phosphodiester bond to C-6 of Nacetylmuramic acid, plays many roles in the peptidoglycan layer. WTA decorates the outer cell
wall and represents about 60% of the total cell wall mass (Neuhaus & Baddiley, 2003). WTA
contains anionic character from phosphate groups that can sequester cations from the
surrounding environment (Swoboda, Campbell, Meredith, & Walker, 2010). This provides the
cell with a reservoir of cations that can be easily accessible for the cells in times of stress. It has
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been suggested that cell wall teichoic acids can create localized changes in pH, indirectly
modulating the function of some enzymes (Biswas et al., 2012). The polyribitol cell WTA is able
to contain modifications on the free hydroxyl groups of ribitol that would allow for additional
cell regulation mechanisms. The WTA is the cell’s protective layer that stabilizes the cell
membrane and provides docking sites for proteins and nutrients as well (Swoboda et al., 2010).
S. aureus strains that do not express WTAs are unable to adhere to nasal, kidney, and spleen
epithelial cells, indicating the reduced virulence of the pathogen (Weidenmaier et al., 2005).
WTA is not vital for cell proliferation but it has been seen to play roles in antibiotic resistance
and increased virulence. WTAs are structurally diverse between organisms and contain various
modifications. A study was performed on the analysis of Listeria monocytogenes WTAs
confirming the presence of a polyribitol-phosphate backbone (Eugster & Loessner, 2011).
Disrupting the biosynthesis of WTAs is a promising target for unique antimicrobial therapeutics.
The pathway of WTA synthesis is not well characterized and many of the mechanisms by which
WTA is able to regulate cell physiology are still ambiguous. Many genes that encode enzymes
within the techoic acid and peptidoglycan synthesis pathways have yet to be identified.
β-lactam Antibiotics
β-lactams are one of the most successful and widely used antibiotics in history (Geddes,
Klugman, & Rolinson, 2007). This class of antibiotics is, however, becoming less effective with
emerging resistance through multiple mechanisms. A pathway of resistance consists of a βlactamase that inactivates β-lactam antibiotics by hydrolyzing the β-lactam ring (Drawz &
Bonomo, 2010). Despite the emergence of β-lactamase inhibitors that have restored efficacy of
the β-lactam class of antibiotics, other mechanisms of antibiotic resistance have emerged.
Methicillin resistant Staphylococcus aureus (MRSA) has achieved β-lactam resistance through
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additional mechanisms, including penicillin-binding protein (PBP2A) which is not susceptible to
β-lactam antibiotics. PBP2A is a transpeptidase that functions in secondary crosslinking of the
peptidoglycan layer (PG). A secondary transpeptidase PBP4 is also found at the division septum,
which generates highly crosslinked PG for cell division. The division septum is the middle
portion of the cell after elongation occurs, and this is the region where cell replication is
occurring. Localization of the PBP4 at the division septum is reliant on the existence of cell
WTA (Atilano et al., 2010). This implies that WTAs play roles in the emergence of antibiotic
resistance in MRSA, and inhibition of WTA synthesis can become the forefront in fighting
antibiotic resistant bacteria.
Research Objectives
The primary goal of this research was to characterize CMS in the MEP pathway from
Listeria monocytogenes responsible for isoprenoid synthesis. Characterization of the enzymes
included, conducting kinetic experiments to extrapolate kinetic constants Km and Vmax. This
research lays a foundation for the development of potential inhibitors for CMS enzymes. A
recently developed HPLC method for the characterization of cytidylyltransferase enzymes was
utilized for the characterizations of CMS 0235 and 1086 (Brault Thesis, 2016). The importance
of isoprenoids in biology and industry are apparent with a broad range of applications as
discussed earlier. A secondary goal was to identify and explain some of the variation in catalytic
activity of CMS 0235 and 1086 by using multiple sequence alignments and structural homology
modeling. The objectives were to detect highly conserved amino acids among CMS enzymes and
indicate areas that would compromise CMS activity of the enzymes. By incorporating protein
modeling we can identify regions of secondary structure that are vital for functionality and
compare and contrast secondary and tertiary structure elements.
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CHAPTER II: METHODS
Cell Transformation of lmo0235
Plasmid DNA containing the gene for CMS 0235 (pet45b-lmo0235) from Shilpa Maroju
(Maroju Thesis, 2008) was inserted into BL21 (DE3)CodonPlus RIL E. coli cells (Agilent),
which are in the class of B strain E. coli. These cells encode a T7 RNA polymerase from
bacteriophage that uses double stranded DNA to catalyze the synthesis of RNA in the 5’-3’
direction.

The

T7

polymerase

recognizes

the

lacUV5

promoter

sequence

TAATACGACTCACTATAG and does not require any additional activators, thus making it
ideal for high-level protein expression systems. Another advantage of using this strain of E. coli
is these cells contain a ColE1-compatible, pACYC-based plasmid containing extra copies of the
argU, ileY, and leuW tRNA genes. Due to the increased expression of a heterologous protein
using the T7 polymerase, some rare tRNAs may be depleted and stall protein expression. These
cells are engineered to be deficient in Lon and OmpT protease proteins which are known to
degrade recombinant proteins (Agilent Technologies, 2017).
BL21 (DE3)CodonPlus RIL E. coli cells (Agilent) were placed on ice and allowed to
thaw slowly and 50 μL of cells were then placed in a 14 mL sterile polypropylene tube,
containing 1 μL of pet45b-lmo0235. The mixture of DNA and cells were incubated on ice for 30
minutes then placed in a 42 oC water bath for 30 seconds to heat shock the cells. This allows for
the membranes to become more fluid and porous allowing the plasmid DNA to enter the host
cell. Following the heat shock phase, the tube is placed back on ice for 2 minutes as a recovery
phase. Following the recovery phase an additional 1 mL of LB medium is pipetted into the tube
and incubated in a shaker at 37 oC for about 1 hour while shaking at about 250 rpm. The cells
were plated on agar plates containing 100 μg/mL ampicillin and 34 μg/mL chloramphenicol. The
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plates contained the antibiotics to serve as a selection process for the cells. Two plates were used,
one contained 20 μL and the other 200 μL aliquots of cells, since transformation efficiency is
unknown. The cells are spread using sterile glass beads and plates are incubated overnight at 37
o

C. Colonies that grow on the plates are presumably the cells that have uptaken the pet45b-

lmo0235 plasmid containing the antibiotic resistant genes.
Cell Transformation of lmo1086
Plasmid DNA containing the lmo1086 gene for CMS 1086 (pet45b-lmo1086) from
Shilpa Maroju (Maroju Thesis, 2008) was inserted into ArcticExpress (DE3) RIL competent
cells (Agilent) for improved protein expression. When using high-level expression systems for
heterologous protein, it can result in the synthesis of misfolded and insoluble protein. When
lmo1086 is expressed in BL21 (DE3) CodonPlus RIL E. coli cells, the protein produced is
insoluble and is not suitable for kinetics assays (Maroju Thesis, 2008). Some labor intensive in
vitro methods call for the unfolding and refolding of these insoluble aggregate proteins. To
bypass this, ArcticExpress (DE3) RIL cells can be utilized to yield properly folded soluble
recombinant protein. ArcticExpress cells have been specially engineered to express the
GroEL/GroES chaperonin complex for improved protein folding activity at low temperatures.
The cells contain the Oleispira antartica Cpn10 and Cpn60 chaperonins that have optimal
activity at 4-12 oC. The ArcticExpress strain also contains a T7 polymerase and lacUV5
promoter for protein expression (Agilent Technologies, 2017).
The cell transformation process is similar to the lmo0235 procedure. An important
modification is the antibiotics used for the selection process. For the lmo1086 in ArcticExpress
(DE3) RIL cells, the antibiotics streptomycin, gentamycin, and ampicillin must be used.
Gentamyacin resistant genes are on the plasmid containing the Cpn10 and Cpn60 genes for the
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chaperonin proteins (Agilent Technologies, 2017). In order to retain the plasmid containing these
genes the cells must be grown in medium containing gentamycin.
Expression of lmo0235 in BL21 (DE3)CodonPlus RIL E. coli Cells
Following the overnight incubation of cells that are plated on agar plates, colonies were
picked for large-scale protein synthesis. A colony containing pet45b-lmo0235 was picked and
placed into an appropriately labeled 14 mL polypropylene tube containing 5 mL of LB medium.
The sample was then inoculated with 5 μL chloramphenicol (34 mg/mL) and 5 μL of ampicillin
(100 mg/mL). The tube was placed into the shaker at 37 oC at 250 RPM and incubated for about
5 hours. After the 5 hour growth period the contents of the tube were transferred to 50 mL of LB
medium containing 50 μL of chloramphenicol (34 mg/mL) and 50 μL of ampicillin (100
mg/mL), then allowed to incubate in shaker at 37 oC overnight. Following the overnight
incubation, cells were transferred into an Erlenmeyer flask of 1 L LB medium containing 1 mL
of the antibiotics chloramphenicol (34 mg/mL) and ampicillin (100 mg/mL). The flask was
returned to the shaker and incubated for another 3 hours at 37 oC. After 3 hours a 1 mL sample
was removed from the cell culture into a polypropylene microcentrifuge tube and cells were
pelleted at 14,000 RPM for 1 minute using a microcentrifuge (FORCE Micro); this will serve as
a control, known as the uninduced sample. The supernatant was discarded and the pellet
resuspended in 1X SDS buffer solution then stored at -20 oC. The 1 L culture was then induced
with 0.05 g of IPTG, (Molecular Biologicals International Inc.), and placed back in the shaker
for 3 hours. During this final 3 hour time period the cells are forced into a high level of
expression of the CMS enzyme. At this point another 1 mL sample was removed and treated like
the previous uninduced control sample. The 1 L culture was then centrifuged at 5,000 RPM for 5
minutes at 4 oC using a J25-I centrifuge and a JLA-10.5 rotor. Following centrifugation, pelleted
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cells were resuspended in 20 mL of cell lysis buffer (50 mM Tris, 100 mM NaCl at pH 7.5),
frozen at -20 oC; for analysis, cells were thawed then lysed using a French Press, and used for
protein purification.
Expression of lmo1086 in ArcticExpress (DE3) Competent E. coli Cells
For high level protein expression, a colony was picked from the agar plate and placed
into a 14 mL polypropylene tube containing 5 mL of LB medium with 50 μg/mL ampicillin, 20
μg/mL gentamycin, and 75 μg/mL streptomycin. The culture sample was incubated in the shaker
at 37 oC for 5 hours, and then transferred to a 50 mL flask of LB medium containing the same
antibiotics and allowed to incubate overnight. After the overnight incubation, the culture was
transferred into 1 L of LB medium that contains 50 μg/mL ampicillin, 20 μg/mL gentamycin,
and 75 μg/mL streptomycin and incubated in the shaker for an additional 3 hours at 37 oC. A
sample was removed as the uninduced form of the cells and saved for SDS-PAGE analysis. The
1 L culture flask was then induced with 0.05 g of IPTG and placed in the cold room at 4-12 oC
for 24 hours. Following the 24 hour time period, a sample again was obtained as the induced
sample and analyzed using SDS-PAGE to provide evidence of successful protein production.
Cells were centrifuged and placed in buffer following the same procedure as used for the
lmo0235 cells.
Lmo0235 and lmo1086 Cell Lysis and Purification
Cells were subjected to the French Press (Spectronic Instruments) for cell lysis. A 20 mL
sample of cells was thawed and dosed with 500 μL of inhibitor cocktail (Sigma Aldrich) to
prevent protein degradation. The cells were placed into the French Press at 10,000 psi to lyse the
cells and release the soluble enzymes (lmo0235 and lmo1086) into the buffer. A 1 mL sample
was removed, labeled as crude extract, and frozen at -20 oC for further protein analysis. The
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remaining crude extract was then centrifuged at 15,000 RPM for 15 minutes at 4 oC using a J25-I
centrifuge and a JA-17 rotor. Another 1 mL sample was removed and stored as supernatant at
-20 oC, and the pellet was discarded.
A high affinity cobalt TALON column (Clontech) was used to purify CMS from the
supernatant after centrifugation. Three milliliters of washed TALON Metal Affinity Resin,
stored in 20% ethanol, was poured into a column and 50 mL of lysis buffer was flowed through
to equilibrate the column. The supernatant was diluted with buffer to approximately 50 mL for
enhanced column flow rate. The diluted supernatant was passed through the Cobalt TALON
Metal Affinity column. The CMS enzymes contain a 6x-His tag on the N-terminal end. The
histidine tag on the enzymes interacts with the cobalt on the resin beads and the enzymes are
retained on the cobalt column. Approximately 40 mL of lysis buffer was passed through the
column to remove any unbound proteins and labeled as column flow through (C.F.T). Following
the C.F.T, 30 mL of 10 mM imidazole in lysis buffer was passed through the column to remove
any weakly bound proteins from the cobalt column. This fraction is labeled as the column wash.
Finally, 10 mL of 150 mM imidazole elution buffer in lysis buffer was passed through the
column to remove the CMS enzymes, and 1 mL fractions were collected in microcentrifuge
tubes. All samples collected were subjected to protein determination.
Protein Determination
A Bio-Rad assay (Bio-Rad Inc.) was used to determine protein concentration in purified
samples. The Bio-Rad Protein assay is based on the Bradford method (Bradford, 1976). The
assay involves using an acidic dye, that upon binding of protein, shifts the absorbance of the dye.
In the Bio-Rad assay, Coomassie Brilliant Blue G-250 dye has a λmax at 465 nm. When protein is
added to a solution containing the dye, a shift in λmax is observed from 465 to 595 nm in response
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to protein binding. The absorbance at 595 nm is linear with respect to protein concentration. A
calibration curve using bovine serum albumin (BSA) from 0-20 μg was utilized.
From each elution fraction 10-100 μL sample was diluted in 200 μL of Bio-Rad assay
dye and enough water to achieve a total final volume of 1 mL. Each sample containing the BioRad dye and protein was analyzed using a UV-Vis spectrometer (Evolution 250 BIO by Fisher
Scientific). When all fractions are analyzed, the fraction with the highest concentration of protein
is chosen for the enzyme assay.
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE), is a common
method used for the separation of proteins by apparent molecular mass by applying an electric
field across the gel (Laemmli, 1970). Lauryl sulfate (SDS) is an anionic detergent, which
denatures protein and binds to the proteins to produce an overall negative charge. The negative
charges on SDS are strongly attracted toward an anode (positively-charged electrode) in an
electric field and cause the migration of protein through the gel. When proteins are denatured
into their linear polypeptide chains, SDS molecules interact with each protein similarly so they
contain uniform charge to mass ratios. The migration distance of each protein is inversely
proportional to the log of its mass. Running a sample of protein standard that contains known
molecular mass proteins on the same gel and plotting migration distance vs. the log molecular
mass will produce a standard curve that can be used to determine unknown protein masses. A
typical SDS-PAGE gel contains two portions, a resolving and a stacking gel portion. The
stacking gel is the upper portion of the gel that is responsible for compressing the loaded protein
sample into a thin layer prior to reaching the resolving gel. This allows all proteins to enter the
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resolving gel at the exact same time. The resolving gel is the portion that is responsible for the
separation of the polypeptides by mass.
Resolving and stacking gels were prepared for protein analysis. A 12% (wt/v) resolving
gel was prepared by mixing 2.15 mL water, 1.5 mL of 40% acrylamide solution (Fisher), 1.25
mL of 1.5 M pH 8 Tris buffer (USB Corporation), 50 μL of 10% SDS buffer (ACROS), 100 μL
of freshly prepared 10% (wt/v) ammonium persulfate solution (APS) (Fisher Scientific), and 4
μL of tetremethylethylenediamine (TEMED) (Fisher BioReagants). The APS is a source of free
radicals that enhances the polymerization of acrylamide for gel formation. TEMED is used to
stabilize free radicals which aids in the rapid rate of polymerization. The free radicals that are
produced by APS react and form free radicals on acrylamide monomers that then react with other
acrylamide monomers to polymerize. The acrylamide polymerization forms a porous gel that
separates the proteins. The gel is prepared with a pH 8 buffer for more anionic glycine to slow
protein migration and enhanced protein separation. The stacking gel was then poured between
two glass plates with a layer of isopropanol and allowed to polymerize. The resolving gel is
poured to leave approximately 1 cm of space for a stacking gel. A 4% (wt/v) stacking gel was
then prepared with 1.5 mL of water, 250 μL of 40% acrylamide solution, 250 μL of 1.0 M pH
6.8 Tris buffer (USB Corp.), 20 μL of 10% SDS buffer (ACROS), 40 μL of 10% APS (Fisher
Scientific), and 4 μL of TEMED (Fisher BioReagants). The isopropanol layer was then removed,
the stacking gel was poured, and well combs were placed between the plates for sample loading.
The lower pH of the stacking gel favors zwitterionic glycine molecules to increase migration.
Protein samples were prepared by diluting pure protein sample with water and 4x SDS
dye to a desired protein concentration. The 4x SDS dye is a solution containing 270 mM SDS
(ACROS), 6 mM bromophenol blue, 200 mM Tris-HCl (USB), 400 mM dithiothreitol (ACROS),
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and 40% (v/v) glycerol (Sigma-Aldrich). The desirable concentrations to load of pure protein is
about 0.1 μg/μL and for mixtures of protein is 1.0 μg/μL. For pure protein ideal loading amount
is 1-5 μg and for mixtures is 10 μg. Each loading well has the capacity to hold 20 μL of sample.
Protein samples diluted for SDS-PAGE analysis were placed into a boiling water bath for 5
minutes to encourage full denaturation and even coating of SDS molecules along the
polypeptide. Protein standards and samples were loaded into the wells and electrophoresed at
150 V for an hour or until the dye front runs off the gel. Following electrophoresis, the glass
plates were removed and the gel placed into a staining solution. The staining solution contains
Coomassie blue dye dissolved in 45% (v/v) methanol (Sigma) and 10% (v/v) acetic acid (Fisher).
The staining container was placed on a rocker (Labnet International) at 2 RPM for 30 minutes.
The gel was then removed from the staining solution and placed into a destain solution which is
45% (v/v) methanol and 10% (v/v) acetic acid. The destain was then placed on the rocker at 2
RPM to for 1-12 hours to remove any excess dye from the gel. Once destain solution was
saturated with dye it was replaced with fresh solution. The gel was analyzed to obtain molecular
mass information with target protein migration in comparison to known protein standards.
Enzymatic Assay Procedure CMS 0235
CMS 0235 enzyme was diluted with nanopure water (exception of pH profile) to 0.020
μg/μL, to ensure that when 5.0 μL of enzyme is added, the total enzyme in the assay is 0.10 μg.
A previous study showed that using 0.10 μg of enzyme in an assay gives a good signal to noise
ratio for measured product (Brault & Friesen, 2016). A stock solution of each of the substrates
(MEP and CTP) was prepared to a concentration of 20 mM in H2O. Cytidine 5’-triphosphate
disodium salt and 2-C-methyl-D-erythritol 4-phosphate lithium salt were obtained from SigmaAldrich. A solution of 10 mM dithiothreitol (DTT) was prepared for the enzyme assay as well.
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The purpose of DTT in an enzyme assay is to keep the protein in a reduced environment. An
example would be to keep cysteine amino acids reduced on the protein surface as so to retain
enzymatic activity. A final 10x reaction buffer solution was made of 250 mM imidazole
(ACROS) and 500 mM magnesium acetate (EM Industries Inc.) adjusted to a pH of 7.4.
The first assay conducted was a time dependent assay. Ten microcentrifuge tubes were
used as the reaction vessels for the enzyme assay. For the time dependent assay each tube was
loaded with the following: 7 μL of water, 2 μL of 10 mM DTT, 2 μL of 20 mM CTP, 2 μL of 20
mM MEP (Sigma-Aldrich), and 2 μL of 10x reaction buffer. The enzyme and reaction tubes are
set to reach room temperature prior to addition of enzyme. Five μL of 0.020 μg/μL of CMS 0235
were added to each tube to begin the reaction, and placed on a hot plate set to 37 oC. Every 3
minutes a tube was removed and the enzyme reactions were terminated by placing the tubes in
boiling water, which will denature the enzyme. Removing tubes every 3 minutes will cover a
range of 0-30 minutes of reaction time. After each tube was allowed to boil for 5 minutes, the
tubes are centrifuged at 15,000 RPM for 1 minute. This will pellet the denatured protein to the
bottom of the microcentrifuge tube. HPLC vials (CG LifeSciences) were prepared by diluting 15
μL of the enzyme reaction in 276 μL of water to have a total of 291 μL samples in each HPLC
vial. The remainder of the kinetic assays were conducted for 15 minutes.
An assay was performed with varying concentrations of CTP while keeping the
concentration of MEP at 2 mM in every reaction tube. Various concentrations of CTP were
prepared from a 20 mM stock solution of CTP. The reaction tubes (in triplicate) were loaded
similarly to the previous assay with the exception of CTP as concentration was varied with each
tube. Upon addition of CMS 0235, each tube was allowed to incubate for 15 minutes. Reactions
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were terminated and handled the same as the previous assay. Varying MEP enzyme assay was
performed following the same procedure.
A pH profile of CMS 0235 was obtained. A 10x buffer of 500 mM Tris (pka= 8.07), 500
mM glycine (pk1= 2.4 pk2= 9.6), 500 mM phosphate (pk1= 2.2, pk2= 7.2, pk3= 12.3) with 250
mM MgCl2 was prepared and 20 mL aliquots were each adjusted to a desirable pH with NaOH
or HCl. The buffers were prepared to cover a range of pH 4-12. A minor adjustment to the assay
was the enzyme was aliquoted and diluted with 1x pH buffer to 0.020 μg/μL and properly
labeled. Reaction tubes were prepared with 7 μL of water, 2 μL of 10 mM DTT, 2 μL of 20 mM
CTP, 2 μL of 20 mM MEP, and 2 μL of 10x pH buffer. Reactions were initiated with the
addition of 5.0 μL of enzyme. The assay was performed following the same procedure as above.
Various divalent cations were also tested for their effects on enzymatic activity. Various
10x buffers were prepared containing 500 mM imidazole and 250 mM MCl2 (where M= Mg, Ba,
Co, Ni, or Mn) adjusted to pH 7. Reaction tubes were prepared with 7 μL of water, 2 μL of 10
mM DTT, 2 μL of 20 mM CTP, 2 μL of 20 mM MEP, and 2 μL of MCl2 10x buffer. Reactions
were initiated with the addition of 5.0 μL of 0.020 μg/μL CMS 0235 and the tubes were
incubated on a hot plate at 37 oC for 15 minutes. Reactions were terminated and handled the
same as previous assays.
Enzymatic Assay Procedure CMS 1086
An assay was completed to determine if product formation increased with increasing
concentrations of CMS1086. The assay mixture still contained the same contents as CMS 0235,
7 μL of water, 2 μL of 10 mM DTT, 2 μL of 20 mM CTP, 2 μL of 20 mM MEP, and 2 μL of 10x
reaction buffer. Separate tubes were prepared with the assay mixture and then varying amounts
of enzyme (0-1.3 μg CMS 1086) were placed in each tube to begin the reaction. The reaction was
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allowed to incubate for 15 minutes and analyzed following procedures of CMS 0235. Product
formation was low, but it was determined that 1.0 μg would be the optimal amount of enzyme for
further assays.
A time variation assay was performed with 1.0 μg CMS 1086 over the range of 0-285
minutes. For further assays a time of 150 minutes was selected. All further assays were
conducted under the same procedure as CMS 0235 with the exception of time and amount of
enzyme present in each tube.
HPLC Calibration
A calibration curve was obtained using High Performance Liquid Chromatography
(HPLC). Since the product of the reaction is not available for purchase, CDP-choline was used as
the standard for the calibration. Using CDP-choline as the standard an assumption will be made
that the product CDP-ME will approximately have the same molar absorptivity as CDP-choline.
Figure 4 displays the calibrant molecule CDP-choline as well as CDP-ME, which is the product
of the enzymatic reaction. The chromophore on both molecules are identical which is the reason
CDP-choline was selected to be the calibrant. In separate microcentrifuge tubes were added
varying concentrations of CDP-Choline from 0.00100-0.0500 mM and each tube contained 0.200
mM CTP as well. Each tube was boiled for 5 minutes to simulate the enzyme assay procedure.
After each tube had been boiled, HPLC vials were prepared containing 200 μL of standard and
200 μL of nanopure water, and placed in the autosampler. HPLC conditions are the same as
experimental with a 10 μL injection. A plot with nanomoles of CDP-choline injected vs. peak
area is shown in Figure 5.
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Figure 4. CDP-ME and CDP-choline Structures. Chromophore outlined in red and has an
absorbance at 254 nm.
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Figure 5. HPLC Standard Curve. Peak area plotted as a function of CDP-Choline. Each point
represents a single injection.
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HPLC Method Application
A modified version of a recently developed method for enzyme assay analysis using high
performance liquid chromatography for cytidylyltransferase enzymes was utilized (Brault &
Friesen, 2016). The study showed that the substrate, cytidine triphosphate (CTP) and product, 4diphosphocytidyl-2-C-methylerythritol (CDP-ME) are able to be separated using HPLC (Brault
& Friesen, 2016). Prior assay methods included 14C radioisotope labelling and a colorimetric
assay using malachite green as described by Jim Brault (Brault Thesis, 2016). Using HPLC as
the preferred method allows detection of substrate and product directly. In order to utilize the
malachite green assay, a phosphatase enzyme is required to convert the inorganic pyrophosphate,
a byproduct of the enzymatic reaction, to free phosphate (Bernal, Palacin, Boronat, & Imperial,
2005). The free phosphate is then reacted with the malachite green dye to produce a green
product, which can then be determined spectrophotometrically. Also, HPLC advantages exist
over the isotopic labeling due to more limited waste disposal as well as a more cost effective
alternative for the assay (Brault & Friesen, 2016).
The HPLC that was used for analysis was a HP series 1100, containing an autosampler
and a PDA Plus detector (HP/Agilent). The column used was a SunfireTM C18 with
measurements of 4.6 mm x 15 cm and 5 μm particle size. A betasil C8 guard column was also
assembled to prevent any contamination of the column and increase column lifetime.
An aqueous mobile phase (0.10 M ammonium bicarbonate) was prepared to an adjusted pH of
7.3, essential for column health and optimal separation of CTP and CDP-ME. The final mobile
phase was 99% buffer and 1% acetonitrile. The HPLC was allowed to run for 45 minutes at
0.500 mL/min to equilibrate the column with the mobile phase prior to sample injection. The
spectra were monitored at 254 nm and the only optically active compounds in the reaction are
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CTP and CDP-ME. An auto sampler was used to inject each sample with an injection volume of
10 μL. Typical chromatograms represent a CTP peak eluting at 3.1 minutes and the product peak
elutes at 4.7 minutes. Since mobile phase was prepared fresh daily it slight differences in peak
elution times (CTP: 3.0-3.3 min. CDP-ME: 4.5-4.9 min.) were observed. The CDP-ME is
slightly more nonpolar than CTP due to its loss of phosphate and addition of erythritol, which
explains the later elution time on a RP-C18 column.
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CHAPTER III: RESULTS AND DISCUSSION
Expression and Purification of CMS 0235 and 1086
CMS 0235 and CMS 1086 were both successfully expressed upon induction with IPTG.
CMS 1086 is a 27.5 kDa protein and CMS 0235 is a 25.9 kDa protein each, with a 6x His-tag at
the amino terminus. SDS-PAGE (Figure 6) confirms that, upon induction by IPTG, the cells
express the proteins, and bands are present in the expected regions of the gel between 25-37 kDa
protein standards. Unfortunately, CMS 1086 was not soluble under the expression system of
BL21 (DE3)CodonPlus RIL E. coli cells as shown by Shilpa Maroju in her thesis work (Maroju
Thesis, 2008). Therefore, CMS 1086 was expressed in ArcticExpress (DE3) competent cells and
successful expression was observed (Figure 7).

Figure 6. SDS-PAGE of CMS 0235 and 1086 Expression Upon Induction of Cells with IPTG in
BL21 (DE3) CodonPlus RIL E. coli Cells. “U” is uninduced, “I” is Induced. Red boxes indicate
position of CMS 1086 (1086I) and 0235 (0235I) on the gel. CMS 1086 was insoluble using
BL21 (DE3) CodonPlus RIL E. coli cells.
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The ArcticExpress (DE3) RIL competent cells display a large band at about 57 kDa
which is the Cpn60 subunit of the chaperonin protein (Figure 7). The Cpn10 subunit is about 10
kDa and not easily identified on the SDS gel since lower molecular mass proteins are more
difficult to identify. Purification gels of both CMS isoforms indicate that the elution fractions
collected display the presence of a prominent band at the correct molecular mass (Figures 8 and
9). The standards of each purification gel were plotted using the log of the molecular mass as a
function of migration distance shown in Figures 10 and 11. Using non-linear analysis, the
experimental values for molecular mass of CMS 0235 and 1086 extrapolated from the curve
were 26.3 kDa and 28.4 kDa, respectively. These are near the theoretical molecular mass of
CMS 1086 and 0235 since both of the proteins on the gel contain a 6x-His tag. The 10 mM
imidazole wash removes some weakly bound proteins and a small amount of CMS visible on the
gel. The enzymes are also found in the crude extract, supernatant (SUP), and column flow
through (C.F.T). The C.E. is the cell extract following the cell lysis procedure which contains all
soluble and insoluble materials. The SUP is aqueous sample after centrifugation and the pellet is
the insoluble material formed upon centrifugation. The C.F.T is the sample collected after the
SUP is flowed through the column, which at this point the CMS should be retained on the
column. Each elution number corresponds to the 1 mL elution fraction from the column upon
eluting enzyme. By SDS-PAGE analysis, it was determined that both CMS isoforms were
successfully expressed and purified for enzyme kinetics.
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Figure 7. SDS-PAGE of CMS 1086 Expression Upon Induction of Cells with IPTG in
ArcticExpress (DE3) RIL E. coli Cells. “U” is uninduced, “I” is induced. Induced lanes display a
band at around 30 kDa that is outlined in red while the uninduced lanes did not. This is an
indication of successful expression of CMS 1086. Samples were loaded twice for clarity.
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Figure 8. SDS-PAGE Purification Gel of CMS 1086. The large band at 57 kDa is the Cpn60
subunit of the chaperone folding protein expressed in ArcticExpress (DE3) cells. The Cpn10
subunit is not visible on the gel, which is theoretically about 10 kDa.

Figure 9. SDS-PAGE Purification Gel of CMS 0235. Elution 1 and Elution 2 are the fractions
collected from the column.
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Figure 10. Plot of Log of Molecular Mass vs Migration from CMS 0235 Purification Gel.
Experimental molecular mass of CMS 0235 was 26.3 kDa.
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Figure 11. Plot of Log of Molecular Mass vs Migration from CMS 1086 Purification Gel.
Experimental molecular mass of CMS 1086 was 28.4 kDa.
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Validation of HPLC
A recent study showed a successful separation of CTP and CDP-ME by using HPLC
(Brault & Friesen, 2016). In the previous study, substrate CTP eluted at about 2.5 minutes and
product CDP-ME eluted at 3.1 minutes. The HPLC conditions used by Jim Brault are outlined in
his thesis (Brault thesis, 2016). In this current study, a modified method was used which included
a guard column and a reduction of eluent (acetonitrile) from 2% to 1%. In this current work a
SunfireTM C18 column was used with a betasil C8 guard column. A slight drop in pH to 7.3 from
7.4 was used to provide sufficient separation and increase column health. Injection of CTP and
CDP-Choline (Figure 12) resulted in sufficient separation with CTP elution at about 3.1 minutes
and CDP-Choline elution time at 3.7 minutes. A second chromatogram in Figure 13 is the
injection of CTP and CDP-ME (from an enzyme assay) and indicates a larger separation was
achieved with CDP-ME eluting at 4.8 minutes. The successful characterization of two CMS
enzymes in this thesis further validates this method for the characterization of
cytidylyltransferase enzymes without the use of coupled assays or isotope labeling.
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Figure 12. HPLC Chromatogram Injecting CTP and CDP-choline Monitored at 254
Nanometers. Elution of CTP is at 3.117 minutes and CDP-choline elution peak at 3.653 minutes.

Figure 13. HPLC Chromatogram Injecting CTP and CDP-ME Monitored at 254 Nanometers.
Elution of CTP is at 3.296 and 3.497 minutes and CDP-ME elution peak at 4.786 minutes. Split
peak for CTP is likely due to multiple protonation states of CTP.
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CMS Enzyme Kinetics
Studying enzyme kinetics is important to understanding catalytic mechanisms, drug
inhibition, and enzyme regulation in metabolism. One of the hallmarks of enzyme kinetics is the
experimental determination of kinetic constants Km and Vmax. These values are determined using
the Michaelis-Menten equation, which is currently one of the most effective models for
investigating enzyme kinetics. Michaelis-Menten kinetics states that the rate of reaction is
dependent on substrate concentration, thus if substrate concentration increases, the rate of
reaction increases as well. Eventually, increasing substrate concentration to the point of enzyme
substrate saturation will reach maximum velocity. The point at which the reaction is considered
to have reached a theoretical maximum of enzyme-substrate complex saturation is referred to as
the Vmax. Using this model, Km is the substrate concentration at which the enzyme is functioning
at ½ Vmax. Michaelis-Menten kinetics fits the model of one substrate and one product, although if
the enzymes of interest have multi-substrate molecules this model can still be applied. In order to
simplify the reaction and apply the Michaelis-Menten kinetics model, one substrate is held
constant at a saturating concentration while the other substrate concentration is varied. Data were
best fit using SigmaPlot (SYSTAT) nonlinear regression analysis, Lineweaver-Burk, Eadie
Hofstee, and Hanes Woolf plots to determine the kinetic parameters Km and Vmax.

Hill Equation:
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=

Michaelis-Menten:
=
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Nonlinear regression analysis using SigmaPlot employed the Hill equation, which is a
powerful tool for the investigation of allosteric regulation. Enzymes that have multiple subunits
may undergo allosteric regulation, which is the effect that a substrate molecule binding to one
active site has on the binding affinity of other molecules on other active sites. The Hill
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coefficient is the “n” term in the Hill equation and provides information on the cooperative
binding of each substrate. If the term is >1 it indicates positive cooperativity, thus a value of less
than 1 indicates negative cooperativity, and a value equal to 1 reflects no cooperativity. Positive
allosteric modulation occurs when the binding of one ligand enhances the attraction between
substrate molecules and other binding sites. A negative cooperativity implies the opposite, that
binding of one ligand decreases the attraction between substrate molecules and other binding
sites, and no cooperativity suggests substrate molecules induce no effect on binding sites.
The conversion of CTP and MEP to CDP-ME as a function of enzyme (μg) for CMS
1086 are reported in Table 1. Product formation was not detected using the HPLC until >0.8 μg
of CMS 1086 was added to the reaction. The assay was conducted with a 15-minute incubation
time, which was not long enough to detect satisfactory levels of product. CMS 0235 results for
varying enzyme were completed in a recently published paper, thus not conducted for this thesis
project (Brault & Friesen 2016).

CMS 1086 in reaction (μg)
0.10
0.40
0.60
0.80
1.0
1.5

Product Peak Area
0
0
0
0
8.4
13.4

Table 1. Effects Of CMS 1086 Added To Reaction And Product Peak Formation. Assay
incubation period was 15 minutes at 37 oC.

The outcome of the CMS 0235 (0.10 μg) assay with time vs. product formation are
plotted in Figure 14, with the linear portion replotted shown in Figure 15. This assay plot
illustrates the reaction incubation time range where product formation is linear with respect to
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time, identifying apparent 1st order kinetics. The line eventually reaches the asymptote, meaning
with increasing enzyme incubation times, product formation is no longer a function of time. This
portion is known to be the 0th order kinetics region. As previously mentioned, a 15 minute
incubation period was selected for CMS 0235 as at this time the enzymatic reaction was still
under apparent 1st order kinetics. Looking at the time dependent assay plot (Figure 16) for CMS
1086, the x-axis (time in minutes) covers a much larger range (0-285 minutes). The much longer
incubation time was necessary for CMS 1086 in order to detect product. Figure 17 is the linear
portion where CMS 1086 is also behaving under apparent 1st order kinetics. The time selected to
perform further assays was 150 minutes. Table 2 outlines the enzyme parameters chosen to
perform further assays. All assays were executed with final reaction volumes of 20 μL.
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CMS 0235 Varying Time
80

Product Peak Area

70
60
50
40
30
20
10
0
0

5

10

15

20

25

30

35

40

45

Time (min.)

Figure 14. Product Formation vs. Time for CMS 0235. Product Peak Area is plotted as a
function of time for CMS 0235
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Figure 15. Linear Region of CMS 0235 Varying Time. This is the region where CMS 0235 is
displaying 1st order kinetics behavior (time 0-20 minutes).
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CMS 1086 Varying Time
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Figure 16. Product Formation vs. Time for CMS 1086. Product Peak Area is plotted as a
function of time for CMS 1086.
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Figure 17. Linear Region of CMS 1086 Varying Time. This is the region where CMS 1086 is
displaying 1st order kinetics behavior (time 0-180 minutes).
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CMS 0235
CMS 1086

Time of 1st order
kinetics (min.)
15
150

Amount of Enzyme
(μg)
0.1
1.0

Table 2: Overview Of Selected Assay Time Periods And Amount Of Enzyme Used. Final
reaction volumes were 20 μL assay for CMS 0235 and 1086.

Kinetic assays were completed with the varying substrate in individual assays to
determine Km and Vmax values for each substrate and enzyme. The first assay was conducted with
a constant concentration of MEP (2000 μM) and CMS 0235 (0.1 μg) while varying concentration
of CTP in individual reaction tubes (Figure 18). A second assay was conducted, this time with a
constant concentration of CTP (2000 μM) and enzyme (0.1 μg) while MEP was varied (Figure
19). Data were collected and analyzed using the Hill equation to determine CTPKm to be 329 ±
66.0 μM and CTPVmax was 2333 ± 230 nmol/min/mg of CMS0235. The Hill coefficient of the
plot for varying CTP was reported to be 1.31, implying positive cooperativity for binding of
CTP. For the substrate MEP MEPKm was 187 ± 7.37 μM and MEPVmax was 2631 ± 48.6
nmol/min/mg of CMS0235. The Hill coefficient for MEP was calculated to be 1.96, thus
implying strong evidence of a positive cooperative binding mode of MEP.
Evaluation of CMS 1086 was performed similarly to CMS 0235. Upon data analysis
using the Hill equation CTPKm was 950 ± 593 μM and CTPVmax was 19.2 ± 4.84 nmol/min/mg of
CMS1086 (Figure 20). Results with the varying MEP assay determined MEPKm to be 763 ± 337
μM and MEPVmax was 31 ± 5.42 nmol/min/mg of CMS1086 (Figure 21). Hill coefficients for
varying CTP and MEP were 0.878 and 0.877 respectively. Both values are close to 1.0 implying
both substrates are behaving in a little to non-cooperative binding mode.
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Figure 18. Hill Equation Plot for CMS 0235 with Varying Concentrations of CTP. Each data
point is a mean ∓ standard error for n=3 replicates.

Figure 19. Hill Equation Plot for CMS 0235 with Varying Concentrations of MEP. Each data
point is a mean ∓ standard error for n=3 replicates.
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Figure 20. Hill Equation Plot for CMS 1086 with Varying Concentrations of CTP. Each data
point is a mean ∓ standard error for n=3 replicates.

Figure 21. Hill Equation Plot for CMS 1086 with Varying Concentrations of MEP. Each data
point is a mean ∓ standard error for n=3 replicates.
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Lineweaver-Burk Transformation
Prior to the accessibility of powerful non-linear regression software (SigmaPlot),
alternative methods were employed for determination of kinetic constants Km and Vmax. These
methods are known as the Lineweaver-Burk, Eadie Hofstee, and Hanes Woolf plots, which were
simple and useful methods for treatment of enzyme kinetics data. The Lineweaver-Burk plot is
simply a double reciprocal plot of the Michaelis-Menten, thus yielding the equation shown
below. The Lineweaver-Burk is a linear representation of the initial Michaelis-Menten plot and
by using the Lineweaver-Burk (L.W.B) equation in

=

+

format, kinetic constants of Km

and Vmax may be easily extrapolated. Figures 22-25 are L.W.B transformations for both enzymes
and substrates.
Lineweaver-Burk:
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CTP Lineweaver Burk 1086
0.6
0.5

1/rate

0.4
y = 3.47E+01x + 7.86E-02
R² = 0.967
Km= 441
Vmax= 12.7
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Figure 22. Lineweaver-Burk Transformation Plot for CMS 1086 for Substrate CTP. Units of
Vmax and rate are specific activity (nmol/min/mg of enzyme). Each data point is a mean ∓
standard error for n=3 replicates.

MEP Lineweaver-Burk 1086
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Figure 23. Lineweaver-Burk Transformation Plot for CMS 1086 for Substrate MEP. Units of
Vmax and rate are specific activity (nmol/min/mg of enzyme). Each data point is a mean ∓
standard error for n=3 replicates.
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Figure 24. Lineweaver-Burk Transformation Plot for CMS 0235 for Substrate CTP. Units of
Vmax and rate are specific activity (nmol/min/mg of enzyme). Each data point is a mean ∓
standard error for n=3 replicates.
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Figure 25. Lineweaver-Burk Transformation Plot for CMS 0235 for Substrate MEP. Units of
Vmax and rate are specific activity (nmol/min/mg of enzyme). Each data point is a mean ∓
standard error for n=3 replicates.
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Eadie Hofstee Transformation
An alternative option to data analysis can be obtained using another popular linear
transformation plot called the Eadie-Hofstee plot. Plotting the reaction rate vs. the ratio of rate
and substrate concentration will potentially yield a linear plot. The plot will provide us with Km
as the negative slope of the line and Vmax is the y-intercept. Calculated kinetic parameters of Km
and Vmax using the Eadie-Hofstee equation are shown in Table 3. Plots for both enzymes and
substrates are shown in Figures 26-29. In Figure 25, the R2= 0.426 and would not appear to be a
good option to extrapolate kinetic constants from, although in this case these constants did seem
to agree with other methods shown in Table 3.
Eadie-Hofstee :

44

=−

[ ]

+

Eadie-Hofstee CTP CMS 1086
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Figure 26. Eadie-Hofstee Transformation Plot for CMS 1086 for Substrate CTP. Units of Vmax
and rate are specific activity (nmol/min/mg of enzyme). Each data point is a mean ∓ standard
error for n=3 replicates.

Eadie-Hofstee MEP 1086
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Figure 27. Eadie-Hofstee Transformation Plot for CMS 1086 for Substrate MEP. Units of Vmax
and rate are specific activity (nmol/min/mg of enzyme). Each data point is a mean ∓ standard
error for n=3 replicates.
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Eadie-Hofstee plot CTP 0235
2500

2000
y = -451x + 2.52E+03
R² = 0.958
Km= 451 μM
Vmax= 2517

Rate

1500

1000

500

0
0

1

2

3

4

5

6

Rate/[CTP]

Figure 28. Eadie-Hofstee Transformation Plot for CMS 0235 for Substrate CTP. Units of Vmax
and rate are specific activity (nmol/min/mg of enzyme). Each data point is a mean ∓ standard
error for n=3 replicates.
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Figure 29. Eadie-Hofstee Transformation Plot for CMS 0235 for Substrate MEP. Units of Vmax
and rate are specific activity (nmol/min/mg of enzyme). Each data point is a mean ∓ standard
error for n=3 replicates.
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Hanes-Woolf Transformation
The Hanes-Woolf plot is another linear transformation plot of the Michaelis-Menten
equation for rapid determination of Km and Vmax. This plots the ratio of substrate concentration
and reaction rate vs. the substrate concentration. Vmax is equal to

of the line and the x-

intercept of the plot is equal to -Km. Refer to Table 3 for the values calculated using this method.
Hanes-Woolf plots were created for both enzymes and substrates (Figures 30-33).
Hanes-Woolf :

[ ]

=

[ ]+

Hanes-Woolf CTP 1086
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Figure 30. Hanes-Woolf Transformation Plot for CMS 1086 for Substrate CTP. Units of Vmax
and rate are specific activity (nmol/min/mg of enzyme). Each data point is a mean ∓ standard
error for n=3 replicates.
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Figure 31. Hanes-Woolf Transformation Plot for CMS 1086 for Substrate MEP. Units of Vmax
and rate are specific activity (nmol/min/mg of enzyme). Each data point is a mean ∓ standard
error for n=3 replicates.
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Figure 32. Hanes-Woolf Transformation Plot for CMS 0235 for Substrate CTP. Units of Vmax
are specific activity (nmol/min/mg of enzyme). Each data point is a mean ∓ standard error for
n=3 replicates.
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Figure 33. Hanes-Woolf Transformation Plot for CMS 0235 for Substrate MEP. Units of Vmax
and rate are specific activity (nmol/min/mg of enzyme). Each data point is a mean ∓ standard
error for n=3 replicates.

The use of linear transformation plots have been superseded by powerful non-linear
regression software like SigmaPlot, as they provide far more accurate results. Table 3 represents
the various methods used for determining values Km and Vmax. Most of the values of Km and Vmax
for CMS 0235 and 1086 are in agreement with each other despite using multiple methods. An
outlier was observed using the Lineweaver-Burk equation in determining MEPKm and MEPVmax for
CMS 0235. This is an example of inaccuracies in linear transformation methods compared to
non-linear regression analysis. The L.W.B indicates a MEPKm value of 1540 μM for CMS 0235,
and upon inspection of Figure 25, it is certainly obvious this value places MEPKm at the
asymptotic portion of the curve. A feature of the L.W.B plot is the lower concentration points on
the Michaelis-Menten curve are heavily weighted in determination of the slope and trend line in
the L.W.B plot. Also, CMS 0235 indicates a positive cooperative binding curve with MEP,
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which introduces some complexity to accurately determining Km and Vmax values using linear
transformation methods.

MEP

L.W.B
Hanes-Woolf
Eadie-Hofstee
Hill Equation

Vmax
8700
3070
3070
2631

CMS 0235
Km CTPVmax
1540
3180
340
3210
312
2520
187
2333

MEP

CTP

Km
581
660
451
329

MEP

Vmax
22.9
26.8
24.8
31.3

CMS 1086
Km CTPVmax
399
12.7
560
16.0
427
14.9
763
19.2

MEP

CTP

Km
441
663
528
950

Table 3. Calculated Values of Vmax and Km Using Linear Transformation Methods And The Hill
Equation In SigmaPlot. All units of Km are μM and Vmax are specific activity (nmol/min/mg of
enzyme).

Evaluation of Km and Kcat of CMS 0235 and 1086
To compare CMS 0235 and 1086, these enzymes have very different activity levels as
can be seen within the data. Kcat values were calculated from Vmax for each enzyme and their
individual substrates. Kcat is the turnover rate, number of product molecules formed by the
enzyme per unit of time. The CMS 0235 MEPKcat is 1.13 s-1 and the CMS 1086 MEPKcat is 0.0143
s-1, which suggests that CMS 0235 converts MEP to product approximately 100x faster than
CMS 1086. A similar observation is made with CTP as CTPKcat for CMS 0235 and 1086 are 1.00
s-1 and 0.0088 s-1 respectively.
Another worthy comparison are the Km values for each of the enzymes, as they provide
information on enzyme substrate binding affinity. Equation 1 shows k1 as the association
constant and k-1 is the dissociation constant for typical enzymes. Since k2 is assumed to be the
rate limiting step and thus very small in comparison to k1 and k-1, the equation is allowed to be
simplified by removing k2. This now shows that Km is directly related to the association and
dissociation constants for an enzyme which correlates to binding affinity.
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Since the Km values for CMS 0235 are lower for both substrates, this suggested that the
enzyme may have stronger binding affinity for each substrate than the 1086 isoform. The larger
Km for CMS 1086 is an indication the enzyme is having trouble binding the substrate properly
most likely due to poor amino acid to substrate interactions. This is translated into having a
larger k-1 and/or smaller k1. In the larger scope of enzymes, CMS 0235 and 1086 are not very
efficient enzymes in respect to their turnover rates. Kinetic constants of Km and Kcat can be used
to calculate catalytic efficiency. An enzyme’s catalytic efficiency (C.E.) is equal to

' (

. The

CTP

C.E. for CMS 0235 and 1086 were calculated to be 3040 M-1s-1 and 9.26 M-1s-1, respectively.

The MEPC.E. for CMS 0235 and 1086 were calculated to be 8248 M-1s-1 and 18.7 M-1s-1,
respectively.
A study was done on enzyme kinetics that used the Brenda database to obtain all Kcat
values for 1942 various enzymes from prokaryotic and eukaryotic organisms (Bar-Even et al.,
2011). The median Kcat was determined to be 13.7 s-1 which is 10x faster than CMS 0235 and is
about 1000x faster than CMS 1086 at converting substrate to product. The same study obtained
Km values of over 5000 enzymes and calculated the median Km of enzymes was 130 μM, and
60% of all enzymes had values ranging from 10-1000 μM (Bar-Even et al., 2011). In comparison
to these literature enzymes, CMS 0235 (CTP, MEPKm= 329, 187 μM) and CMS 1086 (CTP, MEPKm=
950, 763 μM) have “average” values. Catalytic efficiencies were also obtained and the median
was determined to be 125,000 M-1s-1. This indicates that both CMS 0235 (CTP,MEPC.E= 3040,
8248 M-1s-1) and CMS 1086 (CTP,MEPC.E= 9.26, 18.7 M-1s-1) are not efficient when compared to
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the total enzyme pool. These parameters for an enzyme are limited by many factors such as, the
type of metabolic pathway, number of substrates, nature of substrates, and the size of an enzyme.
Although some of these parameters are “low” in regards to the average, it may be by a selective
mechanism. All enzymes cannot improve kinetic parameters ad infinitum, as regulation is
essential in maintaining homoeostasis. Overall, these enzymes exhibit lower enzymatic activities,
but it may be that no evolutionary pressures have forced CMS enzymes to become more
efficient.
pH Profile of CMS 0235 and 1086
Enzymes behave differently under changing pH conditions. pH evaluations of enzymes to
obtain optimum activity are important into understanding the mechanistic behavior of substrate
conversion to product. In some cases pH is a regulatory factor in enzymes and they may be up or
downregulated with changing pH environments. The optimum pH for growth of Listeria
monocytogenes is 7.0 and the pH tolerance is reported from 4.4-9.4 (Lado & Yousef, 2007).
When varying pH, many things may occur, such as changes in protein structure, ionization states
of amino acids, substrate stability, and substrate ionization state. Extreme pH conditions will lead
to disruptions in higher orders of protein structure and may lead to protein denaturation. By
varying the pH environment and modifying the ionization state of amino acid side chains, a
correlation may be observed between ionized state and effects on an enzyme substrate affinity. A
pH profile of both CMS 0235 and 1086 was obtained with a range of pH 4-12 (Figures 34-35).
The pH profile of both enzymes was determined to be similar as they both exhibit pH optimum
activity at pH 8.5. Both isoforms exhibit a pH tolerance range of about 7-10, as most of the
activity is lost outside this pH range. Some unexpected results occurred in the basic conditions of
the pH region. Both enzymes have a Mg2+ cofactor; in basic conditions Mg2+ is precipitated out
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as Mg(OH)2, thus making it inaccessible for the enzyme. Since activity is retained in basic
conditions, it may be that the magnesium ion is not in rapid equilibrium with the environment
but rather more tightly bound in the active site of the enzyme. A second possibility is the Mg2+
does not play a large role in catalysis and may not be very essential to retain enzymatic activity.
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Figure 34. pH Profile for CMS 0235 in Triplicate. Product formation represented as Product
Peak Area as a function of pH. Error bars represent standard error n=3 replicates
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Figure 35. pH Profile for CMS 1086. Product formation represented as Product Peak Area as a
function of pH.
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Divalent Cation Exchange
Some enzymes require cofactors to perform catalysis. Cofactors can act in a variety of
ways by enhancing protein stability, binding substrate, provide platform for oxidative/reduction
chemistry and/or stabilizing transition state intermediates. Enzymes without their cofactors are
called apoenzymes, which is an enzyme in its inactive form; however, not all enzymes require
cofactors. In cases of fluctuating environmental conditions, certain metal cofactors may become
scarce which would induce physiological stress on organisms. In some instances, the use of
cations in enzymes is a tool for regulation by providing an on off switch for enzymes. When
organisms grow in resource depleted environments they are often able to overcome the
challenges associated with minimal resources. Some mechanisms in doing so include enzyme
cofactor substitution. Cytidylyltransferases typically require a Mg2+ metal cofactor. Some
isoforms of CMS are not responsive to various divalent cations while others are less sensitive to
divalent cation substitution (Tsang et al., 2011; Gabrielsen et al., 2004). In this study we
substituted the Mg2+ divalent cation in the assay buffer with Mn2+, Ni2+, Ba2+, and Co2+ for both
isoforms of CMS. CMS 0235 and 1086 both responded similarly with each substituted cation
(Figure 36). Exchanging the cofactor for Ba2+ responded the best, displaying moderate activity
relative to Mg2+. Substitution of Ni2+ also revealed that both CMS isoforms are able to function
with this metal cofactor. With Co2+ both isoforms displayed greatly reduced activities, suggesting
this substitution is possible but not ideal. Manganese (II) resulted in the least activity, with only a
mild retention of activity for CMS 0235 and no activity for CMS 1086. The results suggest these
enzymes are di-cation dependent but still functional with a few other divalent cations. In times of
stress without access to Mg2+, Listeria monocytogenes is likely able to incorporate other divalent
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cations into CMS for survival. This can be an attributing factor for why L. monocytogenes has
the ability to survive in numerous environments.

Divalent Cation Exchange
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CMS 0235
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0
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Mn

Ba

Ni

Co

Divalent Cation

Figure 36. Divalent Cation Assay Results. Normalized activity plotted as a function of divalent
cation for CMS 1086 and CMS 0235. Each concentration of cation in the reaction was 25 mM.
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Sequence Analysis of CMS Enzyme Isoforms
Kinetic analysis of enzymes, although vital to development of potent inhibitors and
helpful in understanding mechanisms, is not the only technique necessary for characterization of
enzymes. Enzymes are typically protein molecules that are synthesized by living cells to catalyze
biochemical reactions. Not all enzymes are proteins, as there are known catalytic RNA
(ribozymes) that are involved in RNA processing. Proteins are composed of amino acids that are
linked together by peptide bonds and range from a few amino acids to thousands. Proteins are
classified into orders of structure known as primary, secondary, tertiary, and quaternary
structures. The simplest form of protein structure is the sequence of amino acids, which is known
as the primary structure. A secondary structure of a protein is the next level of protein structure
and is a segment of the protein that folds into a set conformation based on favorable near
neighbor amino acid interactions. The most common secondary structures are β-sheets (parallel
or antiparallel), α-helices, and β-turns. Tertiary structure is simply the three dimensional
structure of a protein due to amino acid side chain and backbone interactions. Some proteins
contain a fourth level of protein structure, which is when multiple subunits (which may be the
same or different) of protein form a larger protein complex recognized as quaternary structure.
An enzyme’s functionality is contingent on the integrity of the native protein folding
conformation. If an enzyme is denatured so that some of the orders of protein structure are
disrupted, activity may be lost. Some enzymes also contain cofactors (inorganic ions),
coenzymes (vitamins, organic nutrients), and covalent modifications (phosphorylation,
glycosylation) to regulate enzyme activity. Enzymatic activity is correlated with protein
structure, and sequence analysis was conducted to elucidate possible explanations for varying
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activities between isoforms of CMS. Refer to Table 4 for sequence alignment identification and
locations.

Sequence
alignment ID
lmo0235
lmo1086

PDB Code
-

Accession
Number
CAD00762
CAC99164

lmo3F1C
OUT00427
Camjej

3F1C
-

CAC99164
OUT00427
AL139079

1INI
1W77
5HS2
2YCS
1VGT
4JIS
2VSH

NP_218099
CAJ79964
AAF43207
1INI_A
1W77_A
5HS2_B
2YC3_A
1VGT_A
4JIS_A
2VSH_A

Myctu
Fratul
Athal
Ecol, EcoliCM
Arabdop
Bsub5HS2
Atal2YC3
Ecol1VGT
Bsub4JIS
Spn2VSH

Organism

Enzyme

L. monocytogenes
L. monocytogenes

CMS
CMS

Figure
location
38,39,40,46
38,39,40,46

L. monocytogenes
CMS
38,39,40,46
L. planturm
RCT
46
C. jenjuni
Hypothetical
40
ispDF
M. tuberculosis
CMS
40
F. tularensis
CMS
40
A. thaliana
CMS
40
E.coli
CMS
38,39
A. thaliana
CMS
36
B. subtilus
CMS
46
A. thaliana
CMS
46
E. coli
CMS
46
B. subtilus
RCT
46
S. pneumonicos
RCT
46

Table 4. Legend for Sequence Alignments And Their Location. PDB codes are given for known
structures and accession numbers are provided. Also provided is the organism the enzyme is
from and the enzyme type (CMS or RCT). ispDF is a bifunctional enzyme, a product of gene
fusion (ispD + ispF). IspF is 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase or MCS
from the MEP pathway.
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Structures of CMS 0235 and 1086 from Listeria monocytogenes have not been reported,
so a multiple sequence alignment was constructed with other known structural isoforms of CMS
(Figure 38). Refer to Table 6 for key amino acid equivalents. Amino acids have varying
properties, nonpolar, polar, aromatic, positively charged and negatively charged (Figure 37).
Many of the amino acids for CMS across the three organisms (Listeria monocytogenes, E. coli,
and Arabidopsis thaliana) are not “conserved”, meaning each protein contains the same amino
acid at an analogous location. This shows that at many locations on an enzyme an amino acid can
be mutated and have little to no effect on enzyme activity. The regions in black from all
sequence alignments specify highly conserved amino acids at that specific location, and grey
regions represent locations of similar amino acids. These conserved areas indicate amino acids
that have a higher probability of being essential in catalysis, which may include binding of
substrates (or coenzymes/cofactors) and/or providing protein structural features necessary for
proper folding.
Blue Amino Acids
Amino acid locations highlighted in blue from Figure 38 are vital to the enzyme’s
function and are theorized to be the active site amino acids responsible for catalysis (Richard et
al., 2004). A mutant study was conducted by mutating each amino acid highlighted in blue,
which resulted in little to no activity for the E. coli isoform of CMS (Richard et al., 2004). The
study concluded that Arg 20, Lys27, Arg167 and Lys213 are largely involved in the stabilization
of the intermediate (Richard et al., 2004). The R20K mutant lost 55% activity while R20A
retained full activity. The authors comment that the Mg2+ is able to stabilize the intermediate and
perform the role of Arg20 when it is absent (Richard et al., 2004). Amino acids Thr140, Asp106,
Thr165, and Arg109 contribute to the binding and
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Figure 37. Amino Acid Structures and Their Respective Three and One Letter Codes. Amino
acids are displayed as their dominant species at pH 7. Red locations indicate side chains with
ionizable functional groups. Structures were made using ChemDraw.
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Figure 38. Multiple Sequence Alignment for Various Isoforms of CMS. lmo0235 is CMS 0235,
studued in this thesis (CAD00762). lmo1086 is CMS 1086, studied in this thesis (CAC99164).
lmo3F1C is a putative CMS structure (PDB: 3F1C). Arabdop is a CMS isoform in Arabidopsis
thaliana (PDB: 1W77). EcoliCM is a CMS isoform from E. coli (PDB: 1INJ). Amino acids
highlighted in blue play major roles in catalysis and have been studied by site directed
mutagenesis (Richard et al., 2004). Red amino acids are involved in substrate binding of CTP but
have not been tested by site directed mutagenesis. Purple amino acids make up the glycine rich
loop that also plays a role in CTP binding. Purple amino acids also have not been tested by site
directed mutagenesis. Refer to Table 4 for sequence alignment information. Sequence alignments
were constructed using kalign (https://www.ebi.ac.uk/Tools/msa/kalign/) and boxshade
(https://embnet.vital-it.ch/software/BOX_form.html).
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stabilization of the substrate methylerythritol phosphate (MEP). Note that Thr140 is part of the
interlocking arm and buries itself in the neighboring subunit.
Red Amino Acids
Amino acids highlighted in red in Figure 39 are amino acids involved in binding of
substrate CTP (ribose and cytidine moiety only) (Richard et al., 2004). Amino acids in red have
not been studied by site directed mutagenesis. These amino acids provide substrate selectivity for
CTP versus other nucleotide triphosphates but are not associated with MEP binding. These
selected amino acids require further analysis.
Purple Amino Acids
A glycine rich loop is relatively conserved in CMS enzymes, highlighted in purple in
Figure 36. This location is known to play a role in binding substrate through backbone
interactions with the cytidine and ribose moiety. In some cases backbone interactions do not
need a conserved amino acid as the backbone of a protein is presumably the same regardless of
amino acid. In this region it may be an exception since glycine and smaller amino acids lead to
secondary structure that other amino acids are unable to provide. This may cause a proper
alignment for backbone substrate interactions. In this thesis, in order to gain further details on
substrate binding and catalytic function, analysis was performed using multiple isoforms of CMS
that have been characterized.
Summary of Results
This section serves the purpose of identifying regions of significant amino acid residues
that are involved in CMS enzyme activity. The blue amino acids are found to be critical for
enzyme catalysis. Mutagenesis studies revealed that activity is severely compromised when
mutating blue amino acids (Richard et al., 2004). Red amino acids have not been tested with
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mutagenesis studies, however it has been postulated that they sequester the ribose and cytidine
moieties of CTP (Richard et al., 2004). Purple Amino acids is the glycine rich loop also
displaying interactions with cytidine and ribose moieties of CTP. Table 5 summarizes an
overview of amino acids and their interactions along with color code on sequence alignments.

Amino Acid
Lys27
Lys213
Arg20
Gly82
Asp83
Arg85
Ser88
Ala107
Asp106
Arg109
Thr140
Pro13
Ala15
Gly16
Thr165

Interaction Location
Side chain
Side chain
Both
Backbone
Backbone
Both
Side chain
Backbone
Side chain
Side chain
Both
Backbone
Backbone
Backbone
Side chain

Amino Acid Color
Blue
Blue
Blue
Red
Red
Red
Red
Red
Blue
Blue
Blue
Purple
Purple
Purple
Blue

Moiety
α-phosphate
α-phosphate/MEP
α-phosphate/MEP
Cytidine
Cytidine
Cytidine
Cytidine
Ribose
MEP
MEP
MEP
Ribose
Cytidine
Ribose
MEP

Table 5. Amino Acids From E. coli CMS (PDB: 1INJ) And Their Respective Substrate
Interactions. Amino acid color is used for rapid identification in sequence alignments used in this
chapter.
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EcoliCM lmo0235 lmo1086 arabdop lmo3F1C
P13
L8
L7
L10
L9
A15
A10
G9
G12
G11
G16
G11
G10
G13
G12
R20
R15
R14
R17
R16
K27
K22
K22
K24
K24
G82
G81
G80
G81
G83
D83
S82
T81
K82
E84
R85
R84
R83
R84
R86
S88
S87
T86
S87
T89
D106
D105
D110
D105
D103
A107
A106
A111
S106
A104
R109
R108
R113
R108
R115
T140
T138
T143
T138
T145
T165
T161
T167
T162
T169
K213
K209
K216
K210
K218
Table 6. Amino Acid Equivalents From Various CMS Isoforms.

Sequence Analysis of Listeria monocytogenes CMS Isoforms
A structure of a Listeria monocytogenes CMS isoform was deposited into the Protein
Data Bank (PDB 3F1C) (Patskovsky et al., 2008). In this thesis the Listeria CMS from the PDB
will be referred to as CMS 3F1C. A multiple sequence alignment was constructed including the
two isoforms of CMS (0235 and 1086) that were characterized in this project, and CMS 3F1C.
The sequence alignment reveals a high percentage (78%) of conserved amino acids between
CMS 1086 and 3F1C. Due to the high amount of conservation between them, it is likely that
both of these enzymes are products of the same gene. However, the Listeria monocytogenes
culture used to clone the gene used in this study was slightly different from the culture used by
the other investigators cloning the genes used to produce the CMS 3F1C protein. As was shown
in the results section of this thesis, both CMS 0235 and CMS 1086 displayed CMS enzyme
activity, therefore it is expected CMS 3F1C would exhibit CMS activity. Since CMS 3F1C
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resembles a more conserved sequence with CMS 1086, the overall activity expected would be
similar to that of CMS 1086. So the question is, why is the activity of CMS 0235 much higher
than the CMS 1086 for conversion of MEP to CDP-ME?
Blue Amino Acids
According to Figure 39 and Table 7, all of the amino acids speculated to exhibit active
roles in catalysis (indicated in blue) are conserved between all 3 CMS isoforms. This is evidence
that the variance in enzyme activity of CMS 0235 and 1086 is not from the key active site amino
acids.
Red Amino Acids
Possible locations of interest are S82 and S87 of CMS 0235. These locations are essential
for substrate binding of the cytidine and ribose moieties of CTP (Richard et al., 2004). The
equivalent amino acids of S82 and S87 from CMS 0235 are T81 and T86 from CMS 1086
respectively, indication that serine has been substituted for a threonine at both positions (Table
X). Although serine and threonine are similar amino acids, both contain a hydroxyl group and
are considered polar; they are different due to a methyl group on threonine. An argument could
be that a slight variation in size may lead to the dissimilar levels of enzyme activity due to
protein folding issues or steric hindrance caused by the threonine substitutions in CMS 1086.
Also, G107 of CMS 0235 is equivalent to a A111 in CMS 1086 and A104 in 3F1C. Since this
amino acid is involved in a backbone interaction it may be that the larger side chain of alanine is
disrupting enzyme activity. Despite the amino acid differences addressed here, most of the amino
acids are not conserved in other regions of the protein, and an in-depth structural analysis must
be completed. Further inspection of S82, G106 and S87 of CMS 0235 may be important in
evaluating enzyme activity.
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Purple Amino Acids
Evaluation of the glycine rich loop from Listeria monocytogenes putative CMS enzymes
reveals some subtle differences. In Table 7 the sites where amino acids are not conserved
between CMS 0235, 1086, and 3F1C have been shaded in purple as they correspond to the
purple amino acids in the sequence alignment. The equivalent amino acid of A10 from CMS
0235 is G9 in CMS 1086. Here a substitution of a glycine for an alanine may cause a tremendous
change in activity, even though both are considered nonpolar amino acids. Glycine is a special
amino acid that contributes to protein structure in ways no other amino acid is capable of doing.
Due to its small size and ability to facilitate tight turns it can position the backbone in various
orientations. In the literature, this loop is reported to interact with the 2’ and 3’ hydroxyl groups
on the ribose of CTP (Obiol-Pardo, Cordero, Rubio-Martinez, & Imperial, 2010). These
interactions are backbone interactions, and this region consists of small amino acids essential for
secondary protein structure. In addition, Q12 from CMS 0235, which is the equivalent of K11 in
CMS 1086, is not conserved between the isoforms of CMS from Listeria. From the literature,
this position has not been fully evaluated but seems to be of lesser importance in the glycine rich
loop. Further assessment of this region is necessary. Since substrate interactions within the
glycine rich loop are facilitated exclusively through backbone interactions, it reduces the
probability of this region as the cause of poor activity for CMS 1086.
Summary of Results
A sequence alignment of CMS 0235, 1086, and 3F1C provides some details that may be
correlated to enzyme activity (Figure 39). The blue amino acids are conserved in all the potential
isoforms, which indicates that the variation in enzymatic activities is not contingent on those
locations. The red amino acids were different in CMS 1086 versus CMS 0235 at locations 82,
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106 and 87 from CMS 0235, and should be evaluated further. Since 3F1C has not been
kinetically characterized, no tangible conclusions can be drawn from this isoform yet. The purple
amino acids display variations at 2 locations, where CMS 0235 contains an A10 and a Q12, CMS
1086 contains a G9 and K11. All locations must be further evaluated.

lmo0235 lmo1086 lmo3F1C
L8
L7
L9
A9
A8
A10
A10
G9
G11
G11
G10
G12
Q12
K11
K13
G13
G12
G14
R15
R14
R16
K22
K22
K24
G81
G80
G83
S82
T81
E84
R84
R83
R86
S87
T86
T89
D105
D110
D103
G106
A111
A104
R108
R113
R115
T138
T143
T145
T161
T167
T169
K209
K216
K218
Table 7. Amino Acid Equivalents From CMS Isoforms In Listeria monocytogenes. Amino acids
that are shaded indicate lack of conservation and match their corresponding colors in the multiple
sequence alignment in Figure 39.
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Figure 39. Multiple Sequence Alignment of Putative Listeria monocytogenes CMS Isoforms.
lmo0235 is CMS 0235 (CAD00762). lmo1086 is CMS 1086 (CAC99164). lmo3F1C is the
putative CMS structure (PDB: 3F1C). Blue locations signify amino acids involved in substrate
binding (cytidine/ribose) and catalysis. Red locations are amino acids involved in substrate
binding only. Purple region is the glycine rich loop. Refer to Table 4 for sequence alignment
information. Sequence alignments were constructed using kalign
(https://www.ebi.ac.uk/Tools/msa/kalign/) and boxshade (https://embnet.vitalit.ch/software/BOX_form.html).
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Sequence Analysis of CMS Isoforms with Known Kinetic Parameters
To further understand how amino acid variations may lead to observed kinetic activities
of CMS isoforms, a sequence alignment was constructed using isoforms from various organisms
(Figure 40). All CMS isoforms used in the sequence alignment have been characterized, and
reported values of Kcat, Km, and assay method are displayed in Table 9. The Kcat values of the E.
coli, Campylobecter jejuni, and Arabidopsis thaliana enzymes are about 10x higher than CMS
0235 and about 1000x greater than CMS 1086. The differences in these values may be due to key
amino acids that are conserved between the highly active enzymes versus less active isoforms.
With these data it may be possible to elucidate amino acids that result in reduced activity of
CMS 1086.
Blue Amino Acids
The amino acids that are directly involved in catalysis are conserved throughout all the
CMS isoforms, suggesting the cause of reduced/activated activity of these enzymes is not due to
amino acids involved in catalysis.
Red Amino Acids
Previously, positions S82, S87, and A106 of CMS 0235 were identified for further
analysis. The equivalent of amino acid S82 in CMS 0235 is not conserved by CMS isoforms
making this position a less likely suspect in reduced enzyme activity for CMS 1086. Variation in
the type of amino acid at S82 of CMS 0235 includes polar, positively charged, and negatively
charged thus suggests that S82 of CMS 0235 may be less significant. In addition, S82 of CMS
0235 interacts through backbone interactions which makes the identity of the side chain
irrelevant. An all-encompassing characteristic is the equivalent of CMS 0235 S82 in all other
isoforms being a hydrophilic amino acid. This is an indication that the side chain of the amino
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acid is solvent exposed on the exterior of the protein, which upon inspection of E. coli CMS
(PDB: 1INJ) looks to be true. CMS 0235 S87 is not completely conserved between all the
isoforms as well. The S87 of CMS 0235 is equivalent to T86 from CMS 1086 and the
Mycobacterium tuberculosis CMS isoform (Myctu). Since Myctu displayed better binding
affinity (CTPKm= 48 μM) for CTP and similar enzyme activity to CMS 0235 (CTPKm= 329 μM), it
can be assured that T86 of CMS 1086 is not an explanation for low enzyme activity. The S87 of
CMS 0235 is expected to interact with the cytidine moiety of CTP through its free hydroxyl
group on the side chain. Since threonine possess a free hydroxyl group as well, it may be able to
facilitate the same interactions as serine. The A106 of CMS 0235 is conserved by all isoforms of
CMS except the Campylobecter jejuni (S181 equivalent of A107 of CMS 0235) and Arabidopsis
thaliana (V98 equivalent of A107 of CMS 0235) isoforms of CMS. Isoforms of CMS from
Campylobecter jejuni and Arabidopsis thaliana displayed good enzymatic activity which shows
these substitutions are viable. The alanine is only involved in backbone interactions making the
exact identity of the amino acid less relevant. CMS 1086 also contained an equivalent alanine at
this location rendering this site not the cause of reduced activity. To précis, by applying known
kinetic parameters of various CMS isoforms and using multiple sequence alignments we were
able to deduce that the S82, S87, and A106 of CMS 0235 equivalents in CMS 1086 were not the
primary explanation for poor activity. Nevertheless, further experimental analysis is expected at
these locations to verify these results.
Purple Amino Acids
The glycine rich loop displays variation in many of the amino acids within this region
including L8, A10, and Q12 from CMS 0235. The first position (L8 in CMS 0235) along the
glycine rich loop is not conserved with three isoforms (Ecol, Myctu, and Fratul) containing an
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equivalent proline. Using the kinetic data, no trends can be made between the three isoforms that
contain a proline and those that do not, implying that this position is likely not responsible for
reduced activity of CMS 1086. The next position in the glycine rich loop that is not fully
conserved is the A10 of CMS 0235. CMS 1086 and the Arabidopsis thaliana (Athal) isoforms
contain an equivalent glycine at this location. Since the Athal isoform displays a 1000-fold
increase in MEPKcat over CMS 1086 but both contain glycine at this position, this is an indication
that this location is not the primary cause of compromised activity in CMS 1086. The final
position along the glycine rich loop which is Q12 of CMS 0235 is not conserved between any
isoforms except Athal. This location is highly variable amongst isoforms as all types of amino
acids are located at the Q12 equivalent of CMS 0235. As mentioned earlier, this location has not
been well understood and is visible in protein crystal structures. Other locations in the glycine
rich loop are well conserved, ruling out this region as a potential indication for varied activity of
CMS 1086. Overall, L8, A10, and Q12 from CMS 0235 are not likely to be interfering with
CMS 1086 activity.
Green Amino Acids
A protein modeling and computational experiment was employed to rationalize the
increased binding affinity the Mycobacterium tuberculosis isoform of CMS has for substrates
CTP and MEP (Obiol-Pardo et al., 2010). Using “Myctu” in the alignment, the outcomes suggest
that amino acids responsible for increased binding affinity are T141 (T141 remained blue in
Figure 40), I142, D193, and T84. D193 and T84 were suspected to coordinate Mg2+ while T141
and I142 were expected to help stabilize the dimerization of the protein and improve binding
affinity (Obiol-Pardo et al., 2010). Since T141 is conserved with all isoforms this site is not of
concern for further evaluation. The Campylobecter jejuni CMS has the highest binding affinity
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(MEP,CTPKm= 20, 3 μM) suggesting it has the best binding affinity of all the CMS isoforms and
does not contain an equivalent threonine or isoleucine at T84 and I142 from Myctu. This
suggests that the mechanisms of Mg2+ binding for these isoforms may in fact be different. At
position D193 of Myctu, CMS 1086 contains an equivalent A194. This is a possible location of
reduced enzyme activity since the other isoforms contain a negatively charged amino acid while
CMS 1086 has a nonpolar alanine. According to structural analysis the E. coli isoform does not
contain protein to Mg2+ interactions, so it may be that Myctu D193 is less relevant in other
isoforms (Richard et al., 2004). Without protein structures of CMS 0235 and 1086, these sites
becomes more difficult to make confident conclusions from. Without validating the proposed
importance D193, I142, and T84 of Myctu by site directed mutagenesis it is not possible to make
a conclusion on these amino acids.
Summary of Results
In this section, it has been reinforced that blue amino acids are still conserved and are not
the suspected cause of reduced enzyme activity for CMS 1086. This sequence alignment shed
light on the relative importance of the red amino acids as well. It was concluded that S82, S87,
and A106 of CMS 0235 which are equivalent to T81, T86, and A111 in CMS 1086 are likely not
causing poor activity in CMS 1086. The purple amino acids also revealed that L8, A10, and Q12
from CMS 0235 and their respective equivalents in CMS 1086 (L7, G9, and K11) are also not
expected to reduce enzyme activity in CMS 1086. This introduces evidence that none of the
purple amino acids are liable for the reduced activity in CMS 1086. Now that all blue, red and
purple amino acid locations have been ruled out as rationale for poor activity of CMS 1086, this
leaves the green amino acids as potential problems. As mentioned the green amino acids were
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determined to be important computationally but available structures of E. coli CMS (PDB: 1INI)
do not support the claims observed computationally.
Using a sequence alignment alone may be inadequate to elucidate the cause of variations
in activity for CMS isoforms, therefore site directed mutagenesis studies are of high value to
confirm some proposed amino acids involved in dimer stability. In addition, kinetic assay
methods are not identical; it is difficult to assess the values properly with variability in assay
method. Assay methods such as malachite green are not direct detection of product formation,
but a coupled enzymatic assay using a second enzyme to achieve detection. Variations in assay
procedures include divalent cation, buffer system, and pH, making a direct comparison of kinetic
parameters problematic. Refer to Table 9 and 10 for the experimental conditions of various
kinetic assays.
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Ecol
P13
A14
A15
G16
F17
G18
R20
K27
G82
D83
R85
A86
S88
D106
A107
R109
T140
M141
T165
E191
K213

lmo0235 lmo1086
L8
L7
A9
A8
A10
G9
G11
G10
Q12
K11
G13
G12
R15
R14
K22
K22
G81
G80
S82
T81
R84
R83
Q85
N84
S87
T86
D105
D110
A106
A111
R108
R113
T138
T143
V139
I144
T161
T167
E187
A194
K209
K216

Athal
L84
A85
G86
G87
Q88
G89
R91
K98
G154
K155
R157
Q158
S160
D180
S181
R183
T212
I213
T236
D162
K284

Fratul
P9
A10
A11
G12
I13
G14
R16
K23
G79
E80
R82
F83
S85
D106
A107
R109
T141
V142
T164
E192
K214

Myctu
P13
A14
A15
G16
S17
G18
R20
K27
G80
S81
R83
T84
T86
D107
A108
R110
T141
I142
T165
D193
K215

Camjej
L9
A10
A11
G12
N13
G14
R16
K23
G73
D74
R76
A77
S79
D97
V98
R100
T129
T147
D169
K191

Table 8. Amino Acid Equivalents From CMS Isoforms With Known Kinetic Parameters. Amino
acids that are shaded indicate lack of conservation and match their corresponding colors in the
multiple sequence alignment in Figure 40.
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Figure 40. Multiple Sequence Alignment From Kinetically Characterized CMS Enzymes. Blue
locations signify amino acids involved in substrate binding (cytidine/ribose) and catalysis. Red
locations are amino acids involved in substrate binding only. Purple region is the glycine rich
loop. Green location is suspected to coordinate Mg2+ and stabilization of interlocking arm in
Myctu. Athal is an Arabidopsis thaliana CMS. Fratul is the Francisella tularenisis CMS
isoform. Ecol is the E. coli isoform of CMS. lmo 0235 and 1086 are the CMS isoforms studied in
this thesis. Myctu is the Mycobacterium tuberculosis isoform of CMS. Camjej is a
Camplylobecter jejuni hypothetical CMS bifunctional enzyme. Refer to Table 4 for sequence
alignment information and accession numbers. Sequence alignments were constructed using
kalign (https://www.ebi.ac.uk/Tools/msa/kalign/) and boxshade (https://embnet.vitalit.ch/software/BOX_form.html).
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MEPK
cat

MEPK
m

E. coli

25.9

(μM)
760

54.1

(μM)
370

Francisella
tularenisis
Mycobacterium
tuberculosis
Listeria
monocytogenes
lmo0235
Listeria
monocytogenes
lmo1086
Campylobecter
jejuni
Arabidopsis
thaliana

1

73

0.8

178

N/A

92

0.8

43

1.13

187

1

0.0143

763

13
26

Organism

CTPK
cat

CTPK

m

Assay
Method
14
C

Reference

329

Malachite
Green
Malachite
Green
HPLC

Richard et
al., 2004
Tsang et
al., 2011
Shi et al.,
2007
This Study

0.0088

950

HPLC

This Study

20

N/A

3

500

N/A

114

13

C NMR

HPLC

Gabrielsen
et al., 2004
Rohdich et
al., 2000

Table 9. Kcat and Km Values of CMS from Multiple Organisms

Organism
E. coli

Francisella tularenisis
Mycobacterium tuberculosis
Listeria monocytogenes lmo0235
Listeria monocytogenes lmo1086
Campylobecter jejuni
Arabidopsis thaliana

pH/Buffer/Cation
7.8/Tris-HCl (398 nmol), MgCl2 (40 nmol),
NaOH (79 nmol), and inorganic
pyrophosphatase 0.7 unit/ Mg2+
8.0 / 100 mM Tris 1 mM MgCl2 100 mU/mL
inorganic pyrophosphatase / Mg2+
8.0 / 50mM Tris, 2 mM MgCl2 / Mg2+
7.5 / 50 mM imidazole 25 mM Mg(OAc)2 /
Mg2+
7.5 / 50 mM imidazole 25 mM Mg(OAc)2 /
Mg2+
8.0 / 100 mM Tris 1 mM ZnCl2 / Zn2+
8.0 / 100 mM Tris, 5 mM MgCl2 0.1 unit
inorganic pyrophosphatase / Mg2+

Table 10. Variability In Assay Buffer From Literature Experiments. Buffer system for each
enzyme assay used to determine kinetic constants from Table 9.
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Structural Homology Modeling of CMS 0235 and 1086
Sequence alignments are useful in the determination of active site amino acids and the
effects sequence variability has on kinetic abilities of enzymes. However, structural modeling is
another tool that may provide information as to why activities of isoforms are different. As
mentioned before, catalytic activity of an enzyme is contingent on protein folding in a proper
conformation. Protein modeling was conducted using Biozentrum SWISS-MODEL (Swiss
Institute of Bioinformatics). This software takes an inputted amino acid sequence and matches it
to amino acid sequences that have known structures deposited into the PDB. The amino acid
sequence can then be modeled into 3-D structures using the PDB structures as templates.
Five PDB structures were selected to be used as templates for modeling CMS 0235.
Modeled versions of CMS 0235 were analyzed using RasMol (Figure 40). One of the templates
used to model the CMS 0235 was a ribitol-5-phosphate cytidylyltransferase (PDB: 4JIS). In
comparison, the structures that were modeled all have similar overall secondary and tertiary
structure. Table 11 shows the total number of helices, sheets, and turns that were modeled for the
CMS 0235 protein. These numbers, although not identical, provide information that some
regions of the enzyme that were random coiled in the template structure have defined secondary
structure in CMS. These differences are not major, as it is not rare that a short sequence of amino
acids is able to form a region of secondary structure depending on favorable amino acid side
chain interactions.
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Figure 41. Modeled Protein Folding of CMS 0235 Using SWISS-MODEL. Images created using
RasMol. Blue regions indicate α-helices, yellow regions are β-sheets, and grey strings are
random coil. (a) CMS 0235 modeled using PDB 5HS2. (b) CMS 0235 modeled using PDB
2YCS. (c) CMS 0235 modeled using PDB 1VGT. (d) CMS 0235 modeled using PDB 3F1C. (e)
CMS 0235 modeled on PDB 4JIS, a putative ribitol 5-phosphate cytidylyltransferase. The white
box is the region of the interlocking arm, red box indicates the P-loop, and green boxes are the
approximate location of the active sites.
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When modeling CMS 1086 the template protein that displayed the highest sequence
homology was a ribitol-5-phosphate cytidylyltransferase (RCT) from Bacillus subtilis (PDB:
4JIS). This result opened up possibilities that the CMS 1086 may be a RCT rather than a MEP
cytidylyltransferase. Comparing all structures modeled relative to a RCT, it was still difficult to
address locations that would differentiate enzymes structurally. Looking at Figure 42, the RCT
model looks to have lower protein order in the interlocking arm region. This difference is slightly
visible but 5 models is a small sample size and the difference may not be the cause of poor
activity of CMS. Table 12, shows the total number of helices, sheets, and turns that were
modeled for the CMS 1086 protein.

CMS 0235
5HS2
2YC3
4JIS
1VGT
3F1C

Helices
21
18
22
19
22

Sheets
28
26
24
27
26

Turns
38
41
45
46
44

Table 11. Secondary Structure Elements For CMS 0235. Number of secondary protein structure
elements present for CMS 0235 modeled on proteins using SWISS-MODEL.

CMS 1086
5DDT
2YC3
4JIS
1VGT
3F1C

Helices
21
20
19
23
22

Sheets
26
26
24
28
24

Turns
46
51
43
46
43

Table 12. Secondary Structure Elements For CMS 1086. Number of secondary protein structure
elements present for CMS 1086 modeled on proteins using SWISS-MODEL.
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Figure 42. Modeled Protein Folding of CMS 1086 Using SWISS-MODEL. Images created using
RasMol. Blue regions indicate α-helices, yellow regions are β-sheets, and grey strings are
random coil. (a) CMS 1086 modeled using PDB 5DDT. (b) CMS 1086 modeled using PDB
2YCS. (c) CMS 1086 modeled using PDB 1VGT. (d) CMS 1086 modeled using PDB 3F1C. (e)
CMS 1086 modeled on PDB 4JIS, a putative ribitol cytidylyltransferase. The white box is the
region of the interlocking arm, red box indicates the P-loop, and green boxes are the approximate
location of the active sites
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Sequence/Structural Analysis of CMS and RCT Enzymes
A study that specified some key amino acids that are conserved in ribitol
cytidylyltransferase enzymes implicated T145, G167, and D137 of Spn2VSH as providing
substrate specificity for a ribitol 5-phosphate (Baur et al., 2009). These amino acids are
responsible for creating a deeper and more hydrophilic binding pocket (Baur et al., 2009). The
reaction catalyzed by RCT alongside that catalyzed by CMS is shown in Figure 43. The
substrates ribitol 5-phosphate (RboP) and MEP are similar but the RboP is more polar and longer
than MEP, suggesting the need for a deeper and more polar binding pocket. The MEP
cytidylyltransferase enzymes do not contain an equivalent of G167 and D137 from Spn2VSH but
rather nonpolar amino acids such as Ile, Ala, and Val depending on the isoform in question.
Figure 46 shows a multiple sequence alignment with 3 ribitol cytidylyltransferases, and 3 MEP
cytidylyltransferases, CMS 0235, 1086, and 3F1C. The T145 of Spn2VSH is conserved by all
the enzymes, however, the G167 and D137 of Spn2VSH are conserved between the 3 RboP
cytidylyltransferase enzymes, CMS 1086, and 3F1C. Figure 44 displays the potential changes of
the active site pocket when glycine and aspartate are substituted for their equivalents, A163 and
I132 of E. coli CMS (PDB: 1INI), respectively. Figure 45 also illustrates the binding pocket of
CMS using a surface map to better visualize the effects of alanine in the binding pocket. A
portion of the structure/sequence is missing in all the CMS enzymes in this alignment outlined
by a green box (Figure 46). For RCTs this region contains a slightly larger α-helix that the CMS
enzymes do not have but the region is in a remote location. This region currently is not well
studied although this location is a fingerprint region that may differentiate RCTs and MEP
cytidylyltransferases. The study also revealed that the RCT from S. pneumonia is active against
MEP, although physiologically irrelevant (Baur et al., 2009). S. pneumonia does not contain any
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enzyme homologs from the MEP pathway but rather contains the genes from the mevalonate
dependent pathway. In this section, evidence is provided that CMS 1086 represents better
sequence homology with RCTs than MEP cytidylyltransferases.

Figure 43. Reaction Catalyzed by Ribitol 5-phosphate Cytidylyltransferase and CMS. (a)
Reaction catalyzed by a CMS enzyme. (b) Reaction catalyzed by a RCT. Images were
constructed using ChemDraw.
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Figure 44. RasMol Models of Partial Active Site Structures From Deposited PDB Files. (a)
Structure of E. coli CMS complexed with CDP-ME (spacefill) and distance of 6.60 A (PDB
1INI). Alanine and isoleucine are both hydrophobic amino acids that are located within the
binding pocket (b) Structure of a known ribitol 5-phosphate cytidylyltransferase from
Streptococcus pneumonia (PDB 4VSH), CDP-ME artificially for comparison purposes. Binding
pocket contains aspartate and glycine allowing selectivity for larger hydrophilic substrates (c)
Structure of putative CMS from Listeria monocytogenes (PDB 3F1C), product CDP-ME also
artificially placed. This structure also contains aspartate and glycine. Comparing the binding
region, it is clear that substitution of glycine for alanine creates a larger binding pocket an
indication of substrate specificity for RboP. A substitution of aspartate for isoleucine also creates
hydrophilic character, also an indication for RboP specificity.
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Figure 45. Partial Active Site Surface Map of CMS from E. coli (PDB: 1INI). PDB ligand
explorer generated picture displaying the short H-bond interaction from the carboxy backbone to
the terminal hydroxide of MEP. A surface map is also shown to identify the steric hindrance the
methyl group on A163 causes. If a longer more polar RboP was introduced into the binding
pocket the methyl group creates a smaller binding pocket. A glycine is conserved at this location
for RCTs which would remove the methyl group and open up the binding pocket creating more
room to accommodate a larger substrate.
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Figure 46. Multiple Sequence Alignment of Ribitol Cytidylyltransferases and MEP
Cytidylyltransferases. Multiple sequence alignment including three RboP cytidylyltransferases
(Spn2VSH, OUT00427, and Bsub4JIS), three methylerythritol cytidylyltransferases (Bsub5HS2,
Atal2YC3, and Ecol1VGT), and the experimental CMS isoforms (lmo0235 and lmo1086). Red
locations indicate regions of highly conserved locations for RboP cytidylyltransferases.
Sequence alignment indicates CMS 1086 and PDB 3F1C, a putative methylerythritol
cytidylyltransferase, contain conserved locations with RboP cytidylyltransferases. Refer to Table
4 for sequence alignment information. Sequence alignments were constructed using kalign
(https://www.ebi.ac.uk/Tools/msa/kalign/) and boxshade (https://embnet.vitalit.ch/software/BOX_form.html).
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Summary of Results
When using the PDB structures as a template, some of the amino acids involved in
binding substrate and in catalysis were not found in the original structure. Similarly, most of the
CMS structures that are deposited into the database are found to be missing the same region of
protein, which is usually about 15 amino acids following the glycine rich loop. Since these are
X-Ray structures using diffractometric techniques, it may be concluded that this portion of the
protein is mobile or disordered in a protein crystal.
The underlying theme to all the structures, for both CMS and RCT, is a homodimeric
protein that contains the interlocking arm and a P-loop region. This P-loop region is suspected to
be an allosteric regulator acting like a seesaw opening and closing the active site upon substrate
binding (Jin et al., 2016). Further work must be completed on the P-loop region as it serves an
important role and may be the cause of allosteric cooperative binding observed for CMS 0235.
Also, all the structures contain a modified version of the Rossmann motif, which is not surprising
since it is commonly found in proteins that bind nucleotides. Overall, a structural sequence
homology analysis revealed that both putative CMS enzymes (CMS 0235 and 1086) are very
well modeled on various CMS isoforms from multiple organisms. However, structural homology
modeling coupled with sequence analysis represents evidence that CMS 1086 is a putative RCT
and not a CMS.
Evidence using structural modeling and sequence alignments indicate that CMS 1086 and
lmo3F1C contain conserved amino acids with known RCTs. These amino acids were Spn2VSH
equivalents of G167 and D137 that created a larger binding pocket favorable for the binding of
RboP.
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CHAPTER IV: CONCLUSIONS
The MEP pathway remains a great source for novel biochemistry and targets for
antibiotic drug development. Developing and improving assay techniques such as HPLC
contributes innovative ways that allow for the analysis of enzymes. Both enzymes characterized
in this project displayed kinetic activity acting as a CMS by converting substrates, MEP and
CTP, to product CDP-ME. The CMS 0235 was concluded to be the much more efficient enzyme
in comparison to CMS 1086. The catalytic efficiency for CMS 0235 for substrates CTP and MEP
were determined to be 3040 M-1s-1 and 8248 M-1s-1, respectively. Catalytic efficiencies for CMS
1086 with substrate CTP and MEP were calculated to be 9.26 M-1s-1 and 18.7 M-1s-1,
respectively. This is a measure of how efficient enzymes are at catalysis. Data show that the
catalytic efficiency for CMS 0235 is about 300x larger than that of CMS 1086. The sequence
analysis of CMS isoforms revealed some information on the trends of catalytic activity and
conserved amino acids. The structure homology and sequence analysis established some
rationale for the poor activity of CMS 1086 by modeling against a ribitol 5-phosphate
cytidylyltransferase (RCT). CMS 1086 was best modeled using a RCT, supplying evidence that
CMS 1086 is a putative RCT enzyme. Using the model and providing sequence alignments of
CMS isoforms and putative RCTs, CMS 1086 displayed similarities with RCTs that the CMS
0235 did not.
CMS 1086: A Ribitol Cytidylyltransferase?
An overall conclusion from sequence alignment and structural modeling is that CMS
1086 is a putative RCT and not a CMS. The National Center for Biotechnology Information
(NCBI) reported CMS 1086 as a CMS gene in Listeria monocytogenes (Tettelin et al., 2000).
Only recently (September 2017) was it identified to be a putative RCT from Listeria
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monocytogenes after a shotgun genomic project was completed (Casey et al., 2016). If CMS
1086 is a RCT, why would it catalyze the CMS reaction, albeit poorly? In this case, it is not a
surprise it was able to behave like a CMS, using MEP and CTP to form CDP-ME. The substrate
RboP and MEP have related features as that the CMS 1086 is able to recognize MEP as a
substrate as well, and catalyze the reaction using MEP and CTP. During homology modeling and
sequence alignments it was determined that these enzymes are structurally similar and this is a
contributing factor for CMS 1086 to display CMS activity. Active sites of RCTs are larger and
the binding pocket is more hydrophilic due to the smaller glycine and hydrophilic aspartate
specific for RboP (Baur et al., 2009). Amino acids in the active site from both RCT and CMS are
conserved, entailing that the mechanistic properties are similar if not identical. Further studies
must be done to expose more properties of both enzymes to better differentiate them, as it is clear
the scientific community is having difficulty differentiating CMS from RCT. Using automated
gene prediction methods and protein homology is not sufficient in estimating gene products. In
this thesis we have demonstrated that CMS 1086 is active against MEP but displays some
structural features consistent with RCTs.
Future Work
The work following the results of this project are to confirm CMS 1086 is a RCT. It
would also be useful to clone the gene encoding the putative CMS (PDB 3F1C) from Listeria
monocytogenes which, according to sequence analysis, may be a RCT as well. Enzyme assays
should be completed with CMS 1086 and the 3F1C to validate their identities as a CMS or RCT.
An additional useful study is to perform site directed mutagenesis experiments on
purported amino acids directly associated with enzyme function. Computational models are a
starting point for analysis but results are based on theoretical calculations and not direct
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observations. Evaluation of the enzymes for dimensions of the active site cavity and postulate
why RboP or MEP are the preferred substrates. Some interesting questions leading into the
future of this project are, is CMS 1086 a RCT, and if so, which amino acids are involved in the
catalysis? Is it possible to mutate the amino acid(s) to open up the binding pocket and switch the
enzyme into being either a RCT or a CMS? Also a RCT has not yet been characterized using the
HPLC method, so the ability to separate product and substrate is still unknown.
The project is also open to developing potent inhibitors of CMS 0235 for the
development of antibacterial therapeutics. Obstacles must be overcome in order to design potent
inhibitors of CMS. This enzyme utilizes CTP as a substrate and a sugar derivative, which are
abundant in all organisms. The dangers of applying a competitive inhibitor approach are evident,
as many enzymes utilize CTP as a substrate. Applications of non-competitive, uncompetitive,
and mixed competition inhibitors should be explored. This thesis lays a foundation for the
development of next generation therapeutics from CMS in Listeria monocytogenes as a potential
target.
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